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C h a p te r 1
IN T R O D U C T I O N

The Internet offers tremendous potential benefits to consumers in terms of
increased convenience, choices and information. Yet, along with such benefits, comes
new risks to consumers, including an increased risk from fraud, deception and
misinformation (FDA and the Internet Conference, October, 1996).
New communication technology, such as the Internet, allow scholars to rethink
definitions and categories. When the Internet is conceptualized as a mass medium, what
becomes clear is that neither "mass" nor "medium" can be precisely defined for all
situations, but instead must be continually rearticulated depending on the situation. The
Internet is a multifaceted mass medium in that it contains many different configurations
of communication. It does so by its very nature. The Internet plays with the sourcemessage-receiver features o f the traditional mass communication model, sometimes
putting them into traditional patterns, sometimes putting them into an entirely new
configuration. Internet communication takes many forms, from World Wide Web pages
operated by major news organizations, to Usenet groups discussing folk music, to E-mail
messages among colleagues and friends. The Internet’s communication forms can be
understood as a continuum. Each point in the traditional model o f the communication
process can, in fact, vary from one to a few to many on the Internet (Morris & Ogan,
1996).
Significant changes in traditional mass media have occurred. These changes are
due to technological advances in the means of electronic distribution and handling of

information. The term most often used to describe the emerging social order is that of
"information society." Briefly, "this refers to a form o f society in which there is a high
and increasing dependence o f individuals and institutions on information and
communication in order to be able to function effectively in almost every sphere o f
activity" (McQuail, 1992, p. 1).
Researchers throughout the world have devoted much attention to the role of
media in the field of health policy. Mass media have come to be recognized as a strong
force in the field of preventive medicine. By focusing on health questions, media may
•*>

enable people to think about lifestyle issues, and perhaps, to change their behavior.
Media-based advertising health campaigns can spread information and knowledge, and at
best, offer deeper insight (Brannstrom & Lindblad, 1994).
Meaning is the core element of the advertising communication process. Among
other reactions, audiences respond to advertising by relating advertisements to their
backgrounds and experiences, distorting information, making attributions and both
deriving meaning from and ascribing meaning to advertisements (Friedmann & Zimmer,
1988).
Internet advertising is fundamentally different from traditional forms o f media
advertising in the sense that consumers must seek out information. Currently, some
marketers address this problem by integrating advertising with content; for example,
using a game, a story or other incentives for the consumer visiting their site. In this
environment, it may become harder to maintain the clear lines that exist between
advertising and program content.
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Pharmaceutical advertising on the Internet is quickly becoming a topic of
conversation for regulators. The U.S. Food and Drug Administration’s Department o f
Health and Human Services FDA and the Internet conference held in late October o f
1996 is indicative of the FDA viewing this as an issue that will continue to grow in
importance and significance. More people will have access to the Internet, and health
care debates will command greater public scrutiny with the constant changes in policies
and procedures (M. Moncavage, interview, Feb. 12, 1997).
The FDA regulates prescription-drug advertising as it currently appears in
various media. However, there is no set regulation for the Internet:

The Internet is an information source, a communication channel, a transaction
vehicle, and a distribution tool. It is the phone, the newspaper, the TV, the
shopping mall, the library, and the coffee shop. It is open 24 hours a day, 365
days a year, available in every comer o f the world. It is making integrated
marketing communications inevitable. It is an end-to-end process. (Gronstedt,
1997, p. 9).

The purpose o f this study is to examine the newest advertising tool, the Internet,
and how pharmaceutical companies advertise their drugs in comparison to the more
traditional print medium of magazines. Functional theory will be utilized as a framework
for studying the Internet (Graber, 1997; Wright, 1976). The method o f study will be a
qualitative analysis of six selected pharmaceutical company Websites and magazine
advertisements from three selected mainstream publications. The literature review
illuminates the research that has been done on various methods o f pharmaceutical
advertising and promotion. The research also summarizes the limited research on the

Internet and how it has been used for advertising purposes. This study poses the
following general research question: How are pharmaceuticals advertised on the new
medium o f the World Wide Web in comparison to another traditional medium such as
print advertising in magazines?

Chapter 2
LITERATURE REVIEW
Advertising is paid, non-personal communication through which an identified
advertiser (e.g., a firm, a nonprofit organization, or an individual) sends a message to a
target audience with the hope o f informing, educating and persuading. Advertising, as
part o f an overall communication program, is a critical marketing and social process that
offers significant value to advertisers, consumers and society (Aaker, Batra, & Meyers,
1992).
Advertising Regulation
The FDA may regulate only those prescription drug promotional activities that
fall within the legal definitions o f labeling or advertising. However, the agency has
defined its authority in this area to cover virtually any material issued or sponsored by a
drug manufacturer. The definitions of labeling and advertising taken together cover all
information, disseminating activities by or on behalf o f a prescription drug manufacturer.
Labeling is defined as any written, printed or graphic matter upon or accompanying the
drug. To be construed as labeling the material need not physically accompany the
product, only "supplement or explain it" (Kessler & Pines, 1990).
Advertising is not specifically defined, but the FDA generally views anything,
other than labeling, that promotes a drug product and that is sponsored by a
manufacturer as advertising (Cohen, 1988). Once an activity falls within the definition of
labeling or advertising, it must meet certain criteria. Labeling for both prescription and
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over-the- counter drugs must contain adequate directions for use. The requirements for
prescription drug advertising differ from those that apply to labeling in one major
respect: rather than carrying the full package insert, prescription drug advertising may
contain a brief summary o f it. False or misleading statements are prohibited. The
agency’s regulations list 33 ways an advertisement may be false or misleading. Most
commonly, advertisements are judged false or misleading if they selectively or
inaccurately represent or report data, or make claims o f superiority, based on less than
adequate and well-controlled scientific studies (Cohen, 1988). Another FDA regulation
is "fair balance" in advertising. In the fair balance test, the FDA views the advertisement
in its entirety to determine whether it presents a balanced account of all clinically relevant
information-risks and benefits (Kessler, 1990).
In recent years, the FDA has asserted its jurisdiction over an array of new
promotional activities. In the FDA’s view, its mandate is to prevent physicians, other
health professionals and consumers from being misled encompasses not only labeling any
traditional advertising, but all promotional activities sponsored or financed by a drug
company. The FDA’s Division o f Drug Marketing, Advertising and Communications
(DDMAC) is empowered to review all promotional materials, but has a small handicap:
because of the First Amendment, it can require submission for review only after the
company has begun to use the ads. This unregulated window of opportunity has
produced a new opportunist, the rogue pharmo-capitalist. The new pharmo-capitalism is
transforming the consumer, once known as the patient, into his own pharmacist (Critser,
1996).
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The FDA’s position is that premature promotion may unfairly raise public and
health professional expectations and also may lead people to believe that the product will
be found safe and effective for a particular use for which there is no substantial evidence
o f safety and effectiveness. This conflict o f vying for top-dog position can be seen in the
immediate marketplace (Kessler & Pines, 1990). (see Appendix A).
The complexity of the market makes it difficult to trace any offenses in
advertising pharmaceuticals. Control is not possible until the product has been placed
into the market. The FDA must then identify the offense, or have to react to consumers’
complaints. Administrative agencies usually are created to deal with current crises or to
redress serious social problems. Throughout the modem era o f administrative
regulation, which began approximately a century ago, the government’s response to a
public demand for action has often been to establish a new agency, or to grant new
powers to an existing bureaucracy. The development o f new technologies often lead to
creation o f new government bureaus to promote and supervise these emerging
industries:
The primary reason why administrative agencies have so frequently been called
upon to deal with such diverse social problems is the great flexibility o f the
regulatory process. An agency’s regulatory techniques and decision-making
procedures can also be tailored to meet the problem at hand. They can influence
conduct through a wide variety o f informal methods (Gellhom & Levin, 1990,
p.2).
It is also not easy to formulate unequivocal criteria for the judgment o f medicinal
claims. The powerful market forces now transforming the dynamics o f therapeutic
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choice will humble medicine and the pharmaceutical industry (U.S. Food and Drug
Administration, 1996).
Advertising Pharmaceuticals
The pharmaceutical industry is geared toward success that depends on creative
advertising more than on innovative research. The information from drug companies is a
powerful influence on prescribing, but the quality of the product information provided is
considered by many to be substandard. It is often incomplete or misleading, and
companies will emphasize the positive aspects o f products, focusing on attributes that
will give the agent a marketing edge, and not to provide all the objective data (including
adverse effects and contradictions) required for comparative analysis (The Lancet,
1993).
A fundamental role of pharmaceutical advertising is to link effective therapy to
individual patient needs. Pharmaceutical advertising transfers to physicians information
on the actions and proper use o f medicines. Advertising is a crucial element of
pharmaceutical innovation. Unless physicians are informed about the treatment
opportunities offered by new medicines, there is effectively no innovation. Advertising
provides physicians with an informed choice o f carefully characterized agents, specific to
the needs o f individual patients (Levy, 1994).
Advertising helps in controlling the price o f pharmaceuticals as companies
compete for market share. Industry expenditures on advertising should be adequate to
meet the objective of effectively linking therapies to individual patient needs. Strong
links will mobilize the inherent potential o f medicines to reduce the use of expensive

services, thereby reducing overall health care costs (Trends in Pharmacy, 1993). The
fact is that the average expenditure per advertisement per medium has increased and that
a relationship exists between the leading drugs advertised and the leading prescriptions
filled, "implies that prescription drug advertising is o f financial benefit to pharmaceutical
manufacturers" (Krupka& Vener, 1985, p. 193).
According to the FDA, the pharmaceutical industry spends more than $10 billion
on promotion every year. By the late 1980!s, o f nearly 16 million patients who visited
doctors for depression, 70 percent ended up in drug therapy. Non-psychiatric physicians
were brought into the prescribing fold (Critser, 1996).
Direct-to-consumer prescription advertising by pharmaceutical companies is
expected to continue growing. From 1991 to 1992 pharmaceutical companies doubled
their spending on direct-to-consumer advertising from $100 million to $200 million. The
number o f pharmaceutical companies advertising directly to the consumer has increased
from two in 1983 to about 15 in 1992. Although the majority o f prescription drugs do
not lend themselves to consumer advertising, drug companies are expected to expand
their efforts (Winters, 1993).
Competitive Media Reporting data indicate that the pharmaceutical industry
spent $1 billion on consumer ads for prescription drugs in the past five years. The
amount more than doubled between 1993 and 1995 (Conlan, 1996). It is likely that in
the absence of industry "promeducation" (educational presentations that are sponsored
by particular pharmaceutical companies), alternative methods for the dissemination of
information on important new drugs would be satisfactorily achieved via the rise of
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publications similar to The M edical Letter and with online databases such as
COLLEAGUE, DIALOG, and GRATEFUL MED. (Deader, 1994).
Pharmaceutical companies compete with one another for market share. Because
the synthetic chemical commodities they produce are frequently similar
pharmacologically and clinically, each company must differentiate its compound in some
way from competing commodities. Corporate competition for market shares is therefore
conducted around advertising and marketing strategies designed to set apart each
compound (Goldman & Montagne, 1985).
However, the money devoted to promotion might be defined as wasteful in a
traditional economic sense because the marginal promotional expenditure does not
produce any increases in primary or selective demand. To remedy this situation,
legislation could be considered for the purpose o f stimulation decreases in the level of
advertising expenditures while encouraging the industry to invest in additional basic
science research (Mackowiak & Gagnon, 1985).
As pharmaceutical companies seek new ways to promote their products, there is
concern about promotion to consumers through patient groups. Pharmaceutical
companies defend this as promoting consumer choice, but by redefining illness and
selling the disease, they create new markets (Consumer Reports, 1992, pg. 143).
The basic principles of a free enterprise system forcing fair prices through
unrestrained competition are more applicable to the pharmaceutical industry now than
ever before because of the advent o f managed care. Managed care is use of a planned
and coordinated approach to providing health care with the goal of quality care at a
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lower cost. This type o f provider usually emphasizes preventive care and often is
associated with an HMO. Pharmaceutical advertising will remain a crucial element, with
an increased emphasis on demonstrating improved outcomes for patients (Thompson,
1994).
Magazine Advertising
Advertising, regardless of medium, employs words, pictures, or some
combination o f words and pictures to communicate a specific message. Along the way,
however, many things occur as receivers process the stimuli contained in the advertising.
Research in the applied area of advertising effectiveness typically utilizes only
recognition or recall measure as a dependant variable, while most research into the area
o f cognitive receiver response has centered only upon verbal processing. In fact, the
general area o f information processing, regardless of discipline, has relied heavily upon
verbal information processing and has utilized recall measures as dependant criteria
(Percy & Rossiter, 1982).
Studies by Mitchell and Olson (1981) and Wright (1979) have addressed the
notion o f imagery in advertising communication, utilizing visual versus verbal stimulus
elements, with beliefs, attitudes, and intentions as dependent variables. Significant
relationships were found, suggesting a mediating role for visual imagery in increasing
cognitive response to advertising. Both verbal and visual elements in advertising can
stimulate imagery, and variations in words and pictures are known to have differentiating
effects upon at least recall measures of communication (Percy & Rossiter, 1982).

12

The way a message is conveyed (pictorially or verbally), whether the viewer is
given some reference point for encoding the picture, and the type of claim made
(objective, subjective, or characterization), have a significant effect on the processing of
the information presented in the advertisements. These differences in processing are also
shown to affect the viewer’s brand attitudes and purchase intentions (Edell & Staelin,
1983).
Communication research interest in the elderly has focused on how they use the
media and how the media portray them. The elderly, particularly women, appear to be
under-represented in magazine advertisements in comparison to the general population.
This pattern holds for many types of magazines. Because an advertisement is seeking to
make a product attractive to its audience in order to encourage its purchase, it may be
that advertising projects a less negative image o f the elderly, in the case o f magazines,
than might have been expected from research on television dramatic programs.
Nevertheless, the scarcity o f the elderly in magazine ads suggests that the elderly are not
considered to play a major role in the consumer society (Gantz & Rainbow, 1980).
Notions about the information, persuasion and orientation of newspaper and
magazine advertising have been tested. Product analysis suggests that the information or
persuasion orientation of an advertisement is a consequence of the kind of product
advertised: familiar products are more likely to be advertised with persuasion than lessfamiliar products, which require more technical information and are more likely to be
advertised with an information orientation. The information or persuasion orientation of
advertising is not a significant issue since product type appears to dictate the mode of

13

advertising. Rather, the real issue is whether some products should, in any form, be
advertised and this can only be resolved by those who pay for the advertising (Marquez,
1977).
Some drug manufacturers were thought to have scaled back their advertising
efforts under the Clinton administration. In 1993, President Clinton had a campaign
plank o f halting price gouging by drug companies. Magazine advertisement sales
departments were at a loss as to how to generate revenue sources. However, most
publishers and ad directors claimed that despite the likelihood o f smaller ad flow as
public pressure on drug campaigns mounted, drug manufacturers had realized that
magazine advertising was far too valuable a medium from which to completely remove
themselves. Even in the face o f lower profits, pharmaceutical companies continued to
tout the health value and scientific benefits of their products (Patz, 1993).
Pathways to Purchasing Drugs
Social scientists were first drawn to pharmaceuticals by critical studies of dubious
practices by the pharmaceutical industry isuch as bribery, fraud in safety testing, dumping
and misinformation (Braithwaite, 1984). The regulation o f pharmaceutical promotion has
created a level playing field. FDA regulations limit communication about a medicine.
Advertising is what many people mean when they speak of promotion, although
advertising is only a small part o f promotion. Relatively little is spent on the high profile
activities visible to the general public. For example, "less than 3 percent of Glaxo's
promotional budget is spent on the types of activities that the public traditionally
associates with promotion-advertising and promotional literature" (Levy, 1994, pg. 328.)
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An investigation by the Senate Special Committee on Aging found that much of
the money drug companies say they spend on research to develop new medicines actually
goes towards researching how to persuade doctors to prescribe their drugs. Drug
companies often give doctors free drug samples, prescription pads, free trips for doctors
and their spouses to attend company-sponsored seminars at posh resorts, "honoraria"
ranging up to $1,000 for being willing to attend, and cash rewards to doctors who write
a certain number of prescriptions (Gilbert, 1992).
In an era when patients have access to the P hysician’s Desk Reference, when
anyone can tune in to the Lifetime cable television channel, when almost every
week, major scientific studies are reported on the evening news, and when the
National Institutes of Health and the FDA themselves sometimes seek to
publicize their own research findings, the regulatory line between scientific
exchange and promotion is extremely fine (Edelson, 1980, p.34).

The producers of a piece of knowledge, in the form of scientific research, often
seek to control or at least influence its dissemination, and there can be difficulties if they
do not appreciate that the perspective o f a journalist is not that o f the producer but o f the
consumer (Wilkie, 1996).
Prescribing a medication is much more than meets the eye. Smith (1980), in a
classic article, lists 27 "latent functions" o f the prescription. A prescription has
psychological effects, it is a means o f communication, it shows power and facilitates
social control, it produces income, and it has symbolic significance. Prescribing is a
social act. It demonstrates the physician’s concern, and is an attempt by doctors to
increase their good reputation (Kamat, 1995). Pharmaceuticals have a social life in that
they follow a definitive process. First, they are prepared, usually in a technologically
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advanced setting, and marketed to wholesale suppliers such as ministries o f health and
private firms, as well as to retailers. Next, they are distributed to consumers by
prescriptions or direct sale. The prescription is an intermediate phase. It provides the
patient only with a piece o f paper that eventually leads to purchase o f the medicine.
After the pharmaceutical has come into the hands of a consumer, it will reach the final
stage of its life, someone will use the medicine with the purpose o f restoring, improving,
or maintaining his or her health. The ways in which a medicine is taken constitute a
crucial moment in its life. "Wrong use" may render its entire life meaningless. Finally,
pharmaceuticals have a life after death. The fulfillment o f their life purpose lies in their
effect on the well being of the person who took them. The pharmaceutical company’s
efficacy is its ultimate and decisive life stage (Van der Geest, 1996).
Traditionally a physician makes the purchase decision for the patient/consumer by
providing him or her with a prescription. In the absence of a managed care mandate for
generic or therapeutic substitution, the patient would then have the prescription filled by
a retail pharmacist of his or her choice. During this process, the patient may receive
information about the medications use, intended effects, and side effects from the
physician during the office visit, from the pharmacist in the pharmacy, and/or from a
leaflet included with the package of medication or provided by the physician or
pharmacies (Van der Geest, 1996).
Because a consumer cannot purchase certain pharmaceuticals legally without a
prescription, pharmaceutical firms who advertise directly to consumers are not looking
for the immediate desired behavioral outcome: purchase. Rather, their objective is to
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encourage some other action on the part of the consumer that moves him or her close to
purchase, such as seeking additional information from a physician, pharmacist, or friend
(Williams & Hensel, 1995).
Waud (1992) indicates that advertising money from pharmaceutical companies
actually comes from the end-user. The money trail comes indirectly from patient's
insurance premiums or even more indirectly from insurance offered as a fringe benefit in
association with their jobs.
Let me point out that my quarrel is not with the drug companies altogether. It is
more with their advertising end. Indeed, I can see no role whatsoever for drug
advertising. I believe that practically all the problems associated with physicians’
interactions with the drug industry would vanish were advertising out o f the
picture (NEJM, 1992, p.353).
Pharmaceutical companies, as well as third-party providers of health care and
their agents, are increasingly trying to cause patients to be switched from their originally
prescribed medication to "me too" drugs marketed by the companies. These attempts
are sometimes referred to as "switch campaigns." Pharmacists have been encouraged by
pharmaceutical companies to identify patients taking a drug and urging patients to
contact their physicians and ask to be switched. The pharmacists would receive a
payment for each prescription thus switched f Kessler, Rose, Temple, Schapiro, &
Griffen, 1994).
Marketers realize that while purchase may be the desired behavior ultimately,
intermediate behaviors may be prerequisites to purchase. Providing information rather
than promotion is a valid and utilized motive for advertising and may be a necessary
condition for most consumer purchases. Furthermore, firms such as pharmaceutical
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companies have multiple target markets, and several paths can lead to purchase (U.S.
Food and Drug Administration, 1996). Pharmaceutical manufacturers have increasingly
focused on the drug-buying public because they know that while the doctor writes the
prescription, the patient often guides the pen. Nearly one-third o f prescriptions for new
products is now written at the request o f the patient, according to the trade magazine
Pharmaceutical Executive (Consumer Reports, 1992, pg. 142).
Because each prescription drug expenditure originates with the issuance o f a
prescription, it is necessary to understand physician prescribing behavior and the factors
that affect it. It is estimated that two thirds of all patient visits result in the writing of a
prescription (Mackowiak & Gagnon, 1985).
There seems to be a generally held but naive view that advertisements are
supposed to make you rush out and buy something. One demonstrates immunity
to advertising simply by not making an immediate purchase. The absence o f that
knee-jerk response is supposed to prove immunity. This is a non sequitur. The
sell is much subtler. All the advertiser may expect is that, other things being
equal, if you subsequently have to make a decision it is more likely to be in the
favor of the advertiser (Waud, 1992, p.352).

To disseminate drug information, there remains a middle person between
physician and patient, applicable to most countries and respected by the public: the local
pharmacist. The pharmacist rather than the doctor is often the person to whom patients
direct questions about prescriptions and to whom they mention side effects. He or she is
also well placed to spot inconsistent or dangerous prescribing, whether by doctor or by
patient’s self-medication (The Lancet, 1996).
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The commodification o f health and health care through the buying and selling o f
medicines has given rise to some lively debates in medical anthropology. The most
prominent critic is Nichter (1989), who on the basis of research in South and Southeast
Asia, remarked that there is a growing tendency to see health as something one can
obtain through the consumption o f pharmaceuticals. He calls this trend "defective
modernization" and rejects it because it impoverishes the concept of health and gives a
"false sense o f health security,” (pg. 370).
Consumers often express a desire to learn about the qualities and potentials of
pharmaceuticals. There is a lack o f understanding of the differential distribution of
knowledge among users and of the channels through which information flows in the
popular sector (Nitcher, 1989).
In addition to this assessment o f the lay population, research was done on the
effects of promotion on pharmaceutical demand among professionals. Mackowiak and
Gagnon (1985) found that in sales calls to physicians and medical journal advertising
there was no correlation between changes in detailing or journal advertising expenditures
and primaiy or selective demand. Moreover the results o f the study also indicated that
(pharmaceutical) firms would be searching for media with larger primary and selective
demand elasticity. Communication routes which show great potential for the future
include direct to consumer advertising, physician cable TV, and on demand product
information and advertising to physicians via a computer terminal in their office practice"
(Mackowiak & Gagnon, 1985, p. 1195).
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Overview of the Internet
Created by the Defense Department in 1969 for fail-safe communications in the
event o f nuclear war, the Internet’s growth in the 1980's and 1990's was largely through
ad hoc contributions by universities and through the private sectors marketing o f
personal computers. By the early 1970's, ARPANET (Advanced Research Projects
Agency) was transmitting databases, software, hardware resources, storage space and
computer power from computer to computer. This in turn, led to a separate military
network (MILNET) for unclassified material. In the late 1970's, several universities
began adding portions to the network, beginning with USENET (Users Network), and in
the early 80's BITNET (for, Because it’s Time Network, a message retrieval service) and
CSNET (Computer Science Network). The network called the Internet was not formed
until 1983, when the Defense Communications Agency reorganized the Pentagons
networks and began requiring certain protocols on all military networks. In April of
1995, the National Science Foundation (NSF), which had become the closest thing to a
federal authority over the Internet, formally turned over all responsibilities for running it
to academia and private industry (CQ Researcher, 1995). As users of the Internet
multiplied, the "domain" extenders required on the standard user’s address were
designed to include ".mil" for military, ".edu" for academia, ".gov." for government,
".com" for commercial and ".org" for organizations. In the following years, various
universities would make contributions to the N et’s usability. The browser called Mosaic
came from the National Center for Supercomputing Applications at the University of
Minois-Urbana. The "gopher" searching tool came from the University of Minnesota.
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Most recently, the World Wide Web came from the European particle Physics
Laboratory in Geneva, Switzerland (U.S. Food and Drug Administration, 1996).
Businesses have become more interested in the Internet since the arrival of the
World Wide Web. It allows companies, organizations and individuals to create their
own "home page," or Internet entry point. Individual home pages allow user interaction
and instant connections to related home pages around the globe (National Science
Foundation, 1994).
The World Wide Web is a widespread information service. It is all embracing in
its capacity to interface to other information systems such a Gopher, WAIS, FTP, etc.
The Web is based on a hypertext system. Hypertext is a system for linking documents to
other related documents. Links are embedded within the text of a document in the form
o f highlighted words or images. Pointing and clicking with a computer mouse most
commonly activates links. When the links are activated, the linked documents are
instantly retrieved and displayed. The linked document itself can contain links to other
documents, and the process can go on indefinitely. Gopher was the precursor to the
Web; however, menu systems are less flexible than hypertext systems in that links can be
set up from menus to information, but not within the information (Sanders, 1996).
The precise number o f Internet users is difficult to gauge. Before the recent
estimate by the Internet Society, the best available estimate was one from late 1994 by
Matrix information and Directory Services, available on-line. It counted 7.8 million
users with computers that provided interactive services, 13.5 million users that could tap
into computers that offered interactive services and a total of 27.5 million users with the

21

capability o f exchanging electronic mail. Observers warned however, that many o f the
accounts and computers counted in such surveys are seldom used (CQ Researcher,
1995).
Technology and the Internet
An important and expanding adjunct of the U.S. Food and Drug Administration’s
regulatory function is the dissemination of information about drugs, medical devices and
other regulated products to health professionals and consumer. An important new
avenue of information distribution is the Internet, especially the World Wide Web. The
Internet is enjoying unprecedented popularity in consumer and professional communities.
For this reason, the FDA now provides a home page for those who want to learn more
about the agency and the products it regulates. The FDA Internet home page
(http://www.fda.gov) provides up-to-date, authoritative information on food, cosmetics,
human and animal drugs biologic and medical devices. It includes easy to use full text
searches and hot links to other FDA documents and to other government Internet sites,
such as the Department o f Health and Human Services site. In addition, users can
download and print documents of interest to them. (Rheinstein & McGinnis, 1996).
Usage studies continue to reflect the growing popularity of the Internet, with
17.7 million computer accounts reported last year, up from 10.3 million in 1995,
according to Forrester Research (CQ Researcher, 1996). A total of 24.9 million
computer accounts are expected to be added by the end o f 1997. The Internet is a
"potentially valuable tool" for the public but "carries risks as well as opportunities." A
proposal for guidelines or policy on Internet prescription drug advertising is promised
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before the end of the year. The Federal Trade Commission (FTC) has jurisdiction over
advertising and marketing. While the drug industry is eagerly awaiting the FDA’s
proposal, "the basic approach is (already) there in the law" (OTC Business News, 1997,
P- .18).
Advertising seeks to capture essential differences between competing products.
(Levy, 1994). Yet, according to Forrester Research, by the year 2000 an estimated S6.6
billion in retail revenues will be generated through the Internet. Furthermore, it can be
assumed that the drug industry would not invest millions of dollars in these
advertisements if their market research had indicated that the advertising campaigns were
limited or of no influence. The avenues through which we receive our drug information
are rapidly changing. Managed-care programs will be giving us more information and
limiting our prescriptions in a variety of ways. Multimedia messages and computerized
information will expand (Bowman, 1994).
Commercial applications o f the Internet are still in their infancy, but in the early
1990's pharmaceutical companies began using Internet Web sites to inform browsers
about some of their products. In addition, most of those sites have hypertext link
connections to other Web sites belonging to the same company, or to an unrelated entity,
such as a voluntary health association or patient bulletin board. They, in turn, may have
hyperlinks to other sites. The FDA is concerned about this and forbids drug companies
from promoting off-label uses. The FDA is concerned about dangerous information
from bulletin boards or elsewhere that might appear to be endorsed by a drug company
because o f a link (Conlan, 1996).
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An increase in the use o f the Internet to disseminate information about
pharmaceuticals and medical devices has caused the FDA to evaluate how its policies
concerning advertising and labeling should be applied to product information on the
Internet and calls into question if additional regulations are needed because of the unique
nature o f the new medium (Snyder, 1996).
The major pharmaceutical companies believe that the Internet will be a key tool
in their future communications mix. Many have plans to expand into other therapeutic
areas, perhaps partnering with other companies. The results of their current efforts,
guided by feedback from their customers, will impact future efforts as well as the
evolution and creation o f other companies' sites within the pharmaceutical industry. In
developing a communications strategy utilizing the Internet, there is no wrong approach;
there are no rules. Many companies are still struggling with how they define the
Internet; some companies see it as an advertising vehicle, some as a communications
tool, some as a combination of the two. Many manufacturers have used the Internet for
product launches or to develop disease resource centers, while others focus on
developing a database o f customers (Carlson, 1996).
Linking is an issue because the FDA does not like companies to use information
that goes beyond official labeling. In the case o f ethical drugs, the FDA has concerns
about whether it is necessary to distinguish online between advertising and promotion to
health care professionals or consumers, since both groups have access to the same
Websites. Every drug company now has information on the Internet. Many sites include
(»
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corporate information directed at investors and the general public, such as quarterly
financial reports (OTC Business News, 1997, p. 18).
The FDA does not have specific rules and regulations that apply to the Internet.
Ms. Melissa Moncavage, Public Health Advisor for the Center for Drug Evaluation and
Research indicated that the pharmaceutical companies advertising on the Internet are
quite varied on their approaches/tactics. "There is no cohesive effort by the
pharmaceutical industry from the DDMAC's point o f view." If anything, Moncavage
believes, "most pharmaceutical companies advertising on the Internet seem to be doing
their own thing. There is variation in the approach. Some companies are targeting the
consumer, others... doctors, and some are simply presenting general information"
(Interview, February, 12, 1997).
The Internet holds a vast potential for health care marketing that is attracting
increased participation by the pharmaceutical industry. The World Wide Web is the
fastest growing media in history, with an estimated 35 million people who have access to
the Internet. In 1994, Business Mailer Inc. reported that more than 120,000 physicians
own computers with modems, and that the rate o f growth is doubling annually (Liebman,
1995).
Results o f a study of health care marketing executives on use and knowledge of
the Internet showed that, o f the executives surveyed, only 16.5 percent were already
using the Internet for marketing purposes. O f those already using the Internet, nearly 75
percent were using the World Wide Web as a marketing tool. Some possible uses o f the
Internet for managed care companies, hospitals, or provider networks include: 1.
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maintaining up-to-the-minute provider networks accessed by subscribers, 2. Maintaining
policy and procedure manuals for employees and providers, and 3. Offering providers
access where only physicians can post questions or comments and see the responses of
both company representatives and other physicians (Brakeman, 1996).
Six characteristics summarize what is new about this new medium. First is the
great volume o f information that is available. Second are the faster gathering, retrieving,
and transmitting o f information. Third is the greater control over the medium by
consumers. Fourth is the greater ability o f senders to target their messages to specific
audiences. Fifth is the greater decentralization o f the media. And sixth is the greater
interactive capacity (Abramson, Arterton, & Orren, 1988). "The quest for information,
especially among inquisitive, assertive, and aging baby boomers, alternately applauding
and assailing ads virtually from birth, make continued growth with health topic
advertising a natural fit with consumers and the Internet" (Conlan, 1996, p. 92).
Information retrieval and communication are two important aspects o f the work
o f pharmacists and pharmaceutical scientists, and the Internet is an ideal medium by
which these activities can be facilitated. The potential of the Internet is now being
recognized, and in a year’s time, several pharmaceutical information resources have
emerged on the World Wide Web (D'Emanuele, 1995).
Information that appears on a homepage may be different from what companies
have traditionally used to promote their products through brochures, sales meeting,
word-of-mouth or sales people going out. All o f these things are available. It should be
clear in terms o f looking at a company’s homepage that it is coming from the company.
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It is impractical for FDA to force disclosure o f a company name on every page or every
screen in a company website, but it should be readily available (U.S. Food and Drug
Administration, 1996).
The Internet makes the issue much more complex because everyone has access to
it. It is impossible for one person, group, or company to control the Internet. The FDA
may regulate what pharmaceutical companies, medical device companies and biologic
companies put on the Internet, but cannot control what consumers or what medical
researchers independently put on the Internet (U.S. Food and Drug Administration,
1996).
The issue comes to a head when a drug company or a device company is
distributing the information. Today if the drug company proactively sends out, for
example, scientific journal articles about unapproved uses of drugs, that would be a
violation that is treated as promotion. On the other hand, if a physician or a patient asks
for a copy o f an article and they know what it is, the company is free to send it out. The
context is really determined by the receiver (U.S. Food and Drug Administration, 1996).
The FDA is concerned that keyword-based advertising on the Internet’s
directories and search engines is unique and superior to advertising on other media. For
advertisers, it offers access to a highly targeted audience on a cost-per impression basis,
while for the search engine companies, it is an easy-to-sell service that commands a
substantial premium over general display ads and banners. (Ubois, 1996).
Product-specific advertising is advancing cautiously on the Internet, because the
FDA has no specific regulations that apply to direct-to-consumer ads. Despite
jazzy graphics and audio, most manufacturers are treating Internet ads for
products much the same way they do print. The FDA is considering different
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requirements for different media, but no decisions have been made (Conlan,
1996, p. 92).

Media Content and Society
For marketers, in general, advertising products which cannot be purchased
directly by consumers can be effective in encouraging members o f the target market to
seek additional information about the products, which ultimately might result in
purchase. Pharmaceutical marketers should coordinate marketing efforts directed at
consumers and their potential information sources, particularly pharmacists and
physicians. ceDTC advertising, being favored by those in poorer health may well
communicate with the perfect target market of pharmaceutical companies: those in poor
health." (Williams & Hensel, 1995, p. 40).
It is a fundamental error to assume that the Internet and the Web, in particular, is
simply an extension o f previous media. If the FDA deems that the Internet is just
another form o f promotion that can be easily regulated with existing rules, then that
makes it easy for the government. If there are differences between the Internet and other
forms of promotion that require special rules, then this becomes a challenge for the
agency (U.S. Food and Drug Administration, 1996).
Yet, the Internet is subject to regulation as specific events have shown in the
past. In 1996, Virgin Atlantic Airways agreed to pay a fine o f $14,000 to the US
Department o f Transportation for putting out misleading advertising on the Internet.
(Keenan, 1996).
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The Internet Advertising Bureau, a trade group representing sellers o f online
advertising space, made its debut in June 1996. The IAB is choosing to narrowly define
advertising along traditional lines, and this is, "not effective in approaching the medium
that is based upon advancing technology, and increasing consumer access" (Advertising
Age, 1996, p. 15).
In 1995, the National Advertising Division (NAD) o f the Council o f the Better
Business Bureau made its first cyberbust at the end of that year, citing a company for
false advertising on the Internet. The ruling, against Infinity Distribution shows that the
NAD's rules will be applied no matter what the medium (Lucas, 1996).
The American Association o f Adverting Agencies has created two disclaimers for
copyright and liability, in case someone takes information from your site and uses it out
o f context on another site. These disclaimers can be used on any website. There is a site
that is for the health o f the NET code o f conduct (www.hon/conduct.html). A non-profit
group in Geneva, Switzerland promulgates it.
The complex forces shaping the pharmaceutical market in the past two years will
continue to reshape it. The negative market forces include: the significant number o f
blockbuster drugs going off patent and the resulting generic and therapeutic substitution,
the lack of major new products replacing off-patent drugs, increasing price competition
and the rising influence o f managed care. Positive market forces include: improved R &
D productivity, aggressive marketing to managed care groups, prescription-tononprescription switch groups, opportunities, and reduced operating expenses (Medical
Advertising News, 1997, p.40).
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Technology is perhaps the dividing line with physician’s views of pro or anti
information dissemination among the lay population. Three elements must be taken into
consideration: 1) What is the message itself? 2) Is it mainly promotional or education? 3)
Who is the audience?
Petroshius and Titus (1995) found that physicians are favorably disposed to the
advertising of pharmaceutical products both to consumers and other physicians, with
differences emerging among physicians based on age, experience, practice setting, type
and specialty.
Petroshius and Titus found older physicians view pharmaceutical advertising less
favorably than younger physicians do. The researchers offered the explanation that older
physicians were trained at a time when "advertising was sort of frowned upon by the
medical community, and little, if any, advertising was directed toward the consumer, "(p.
47). In addition, "younger physicians are more likely to make an effort to keep abreast
o f new developments. They are also more responsive to patient inquiries and requests for
prescription drugs"(p.49). The researchers conclude that this may be due to the
evolution o f consumers becoming more informed about their medical options, when
historically, the physician was viewed by the patient as "all-knowing."
While past research has found consumers to be favorably disposed to the
advertising of pharmaceuticals (Alperstein & Peyrot, 1993), this is of little value to
advertisers unless physicians respond favorably to patients' inquiries for advertised
prescription drugs.
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Petroshius and Titus found that the physicians in their study reported a high
degree o f responsiveness to patient requests for prescription drugs, suggesting
consumer-directed advertising to be an effective promotional tool, especially in light o f
Alperstein and Peyrot's findings that consumers are generally in favor of consumerdirected advertising of pharmaceuticals.
Reflecting the fact that pharmacy benefit managers, managed care groups and
consumers now decide what pharmaceuticals are prescribed, pharmaceutical firms are
turning to advertising agencies for an integrated marketing strategy. Each target
audience requires a specific message. An increasing number o f drug companies are
tracking the entire process of treating an illness, rather than developing medications and
simply marketing the product on the basis o f clinical research. Tracking sales calls can
be an important source of database information, giving companies a way to track the
effectiveness o f their promotions (M edical Advertising News, 1997).
Starting consumers off on the "path to purchase" by encouraging them to seek
more information is a major goal o f direct-to-consumer advertising for prescription
medication. The attitudes o f older adults are especially significant for pharmaceutical
marketers because these consumers are heavy users of the drugs being advertised
(Williams, & Hensel, 1995).
Using current and new technology, pharmaceutical companies realize that the
old and proven ways of doing business are no longer going to work. Reinventing
pharmaceutical marketing, advertising and promotion by capitalizing on the opportunities
offered by technology is a must (Wind, 1994).
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The Internet lends itself to the theoretical construct o f the audience as market
(McQuail, 1987, p. 220). This theory identifies certain characteristics, namely:
it specifies the link between media and their audiences as a consumer-product
relationship, hence "calculative" from the point o f view o f the consumer and
manipulative from the point o f view of the consumer, and manipulative from the point of
view o f the sender. It gives little emphasis to the internal social relationships of the
audience. The audience characteristics most relevant to this way o f thinking are socialeconomic.
Wright (1976) suggests certain levels o f functional analysis for communication
activites.
The fourth level of functional analysis is rather abstract but crucial for the
development o f a functional theory o f mass commuication. Mass
communication, as institutionalized in modem societies, constitutes a social
phenomenon qualitatively and quantitatively different from personalized
communication (Wright, 1976, p. 205).
Lasswell and Wright (1960, 1976) are among the many scholars who have
considered the functions and role o f the mass media in society. Surveillance, the first
function, informs and provides news and information. This includes the information
that is essential to the economy, the public, and society. In performing this function the
media often warn the public o f expected dangers. Graber (1997) suggests that the
surveillance function involve two major tasks. For the political community at large,
public surveillance focuses by publicity on selected people, organizations, and events.
Private surveillance informs individual citizens in their private capacities about current
events.
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Correlation is the second function, and this is the selection and interpretation of
Information about the environment. Correlation is the editorial and propaganda content
of mass media. The correlative function also serves to enforce social norms and
maintain consensus. Through the correlation function the media can often impede
threats to social stability and may often monitor or manage public opinion.

Graber

(1997) believes that by suggesting the causes and relationships of various events, the
media may shape opinions even without telling their audiences what to believe or think.
As socialization, media function to communicate information, values, and norms
from one generation to another or from the members of a society to newcomers. This is
done in a way to increase social cohesion by widening the base o f common experience.
Graber (1997) indicates that most of the new orientations and opinions that adults
acquire during their lifetime also are based on information supplied by the mass media.
Mass media information provides the ingredients that the public uses to adjust existing
attitudes and opinions to keep up with the changing world.
Lastly, most media content is intended as entertainment. Mass media expose
millions to popular culture, music, movies, and television. Two arguments develop for
the entertainment function of media (Wright 1976). One argument is that media
entertainment serves to provide respite from everyday problems and fills leisure time.
Others argue that the media encourage escapism, corrupt fine art, lower public taste,
and prevent the growth o f an appreciation for the arts.
Doris Graber (1997) added manipulation to these functions. Direct
manipulation of the political process is widespread. "After decades o f neutral reporting
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when most American journalists acted primarily as chroniclers o f information provided
by others, media now operate their own investigative units" (Graber, 1997, p. 12). The
reason for the manipulation may be to expose misconduct and produce reforms. Or the
reason may be to attract large media audiences and enhance profits.
Based on the review o f literature on drug company advertising efforts and the
Internet, the following specific questions were used to guide the investigation:

RQ 1. What type o f information is presented? Does it inform the viewer?
RQ 2. What is the correlative nature of the information? What is the editorial content?
Is it educational, promotional, or otherwise?
RQ 3. Does the information provided act as socialization? Does it communicate values
and norms?
RQ 4. Does the information have an entertainment value?
RQ 5. Is the information used for manipulation?

A qualitative analysis was chosen in order to address these questions. Qualitative
research involves the careful, detailed description of that which is under study (Babbie,
1995). Fundamentally, the goal o f qualitative research is to preserve the form and
content o f that which is under study and to analyze its qualities, rather than subject it to
mathematical or other formal codification (Lindlof, 1995).

Chapter 3
METHODOLOGY
The goal of this study was to systematically describe the content o f six
pharmaceutical companies' Web sites for four sample Saturdays over a one month period
in 1997. In addition, three mainstream magazines were examined during the same
month. Advertising for the two different mediums were compared to each other. This
was a descriptive study as well as being exploratory. There exists little research on the
content of the World Wide Web; thus an initial exploratory study was needed to help
explain this phenomena.
Sample
Based on the researchers judgment and the nature o f the study, a purposive
sampling scheme was seen as the best approach (Babbie, 1995). The six pharmaceutical
company web sites which were chosen for study were Merck and Company INC.,
Bristol-Myers Squibb Co. INC., Pfizer INC., Eli Lilly Co., Schering-Plough Corp., and
Ciba-Geigy Corp (see appendix B). The criteria in selecting these six companies were
sales volume and that the company had a web site. Relying upon D un’s Top 50 Business
Rankings (1996) per SIC ranking by sales volume, all six fit the criteria of generated
annual revenue and possessing a company web site.
The Standard Industrial Classification (SIC) is the statistical classification
standard underlying all establishment-based Federal economic statistics classified by
industry. The SIC is used to promote the comparability o f establishment data describing
various facets o f the U.S. economy. The classification covers the entire field of
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economic activities and defines industries in accordance with the composition and
structure of the economy.
Companies were selected by having a website and their main business being
pharmaceuticals. O f the six selections, Merck (4) represents the top-grossing company
with $14,969,800,000 in sales and has a web site (http://www.merck.com/). BristolMeyers Squibb (5) has $11, 984,000,000 in sales and has a web site
(http://www.BMS.com). Pfizer (9) has $8,281,300,000 in sales and has a web site
(http://fdncenter.org/pfizer). Eli Lilly (20) has $5,711,600,000 and has a web site
(http://www.lilly.com). Ciba-Geigy (25) has $4,806,640,000 and has a web site
(http://www.ciba.com). Schering-Plough (27) has $4,657,100,000 and has a web site
(http://www.myhealth.com).
Although the SIC rankings differ from the rankings used in this study (SIC
ranking shown parenthetically), these companies were selected for having prescription
pharmaceuticals as their flagship business rather than the other companies, which have
other business entities under the same respective company name. The SIC 28
classification is for chemicals and allied products which includes industrial inorganic and
organic chemicals, plastics materials and synthetic resins, synthetic rubber, cellulosic and
other manmade fibers; drugs; soaps, detergents, and cleaning preparations; perfumes,
cosmetics, and other toilet preparations; paints, varnishes, lacquers, enamels, and allied
products; agricultural chemicals; and miscellaneous chemical products.
As an example, Proctor and Gamble is ranked first on the SIC list, but their other
product lines are vast, and prescription pharmaceuticals are not their core business as it
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is with, say, Merck which is ranked 4th in the SIC listing, but first for these particular
research purposes as having pharmaceuticals as its core business. Each company from
the SIC list was examined to see if it had a web site based upon the network listing
Netscape for businesses, primarily using the search engine YAHOO! to find the sites.
(http://www.yahoo.com/pharmaceuticals.)
In the same manner, the three mainstream magazines were examined for drug
advertisements that appeared during the month o f May. The three magazines were Time,
Newsweek, and Modern Maturity. The magazines were selected on the basis of their
audience reach as well as their readership. Specific content analysis studies confirm the
status of Time and Newsweek as being typical o f mainstream newsmagazines.
Smith(1990) and Moriarty and Popovich (1991) chose both Newsweek and Time because
“o f their national prominence, large circulation, and blend o f news and feature subject
stories” (Smith, 1990, p. 129).
Taken from the 1995 Audit Bureau o f Circulation, the above mentioned
magazines were selected for their ranking by total average paid circulation and the
factors of recall and market niche. O f the 100 best-selling U.S. magazines, Modern
Maturity is ranked second, Time is ranked 13th, and Newsweek, is ranked 19th. Factors
that come into play for the selection o f these publications are similar to the SIC ranking
of pharmaceutical companies. For example, Playboy was 15th on the list as was Ladies'
Home Journal with a ranking o f 8th place. Although these magazines do rank higher
than both Time and Newsweek, they are obviously targeted for a very core audience.
Time and Newsweek have a broader readership as national newsmagazines. Modern
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M aturity was selected because o f its rank, and for the fact that it appeals to a specific
age group that is more prone to be concerned with health care issues than other age
populations.
Method of Analysis
The sites were selected because they meet the criteria o f being listed in Dun’s
SIC listing, and they each have their own website address. Babbie says that in a
purposive sample, the researcher "selects a sample of observations which (one) believes
will yield the most comprehensive understanding of (one's) subject o f study, based on the
intuitive feel for the subject that comes from extended observation and reflection"
(Babbie, 1995, p. 269).
Study of the websites occurred every Saturday for four-weeks, at 12:00 PM
CST. Measurements and recordings were taken o f each homepage and its links. A copy
was made of each company’s homepage. The first Saturday was the benchmark for the
study, and any differences observed to have occurred were noted. The study went two
links (where allowed) deep into each menu item given on the homepage. The study was
conducted at this specific time, because of time restrictions and computer accessibility of
the researcher. The first step was to assess the homepage. Every Saturday the home
page was printed and described by reporting what appeared on the page, and what links
were available and where they lead. In preliminary research for this project, it was noted
that the homepages have been witnessed to change in all manners, from layout, to
graphics, as well as text and links.
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General categories were company history, drug information, investor relations,
research and development, other.
After the description o f the homepage and an itemization of the links, the menu
items were clicked on in order (top to bottom, and/or left to right). A full description
was given of what the link showed, and the critical probes were used to assess what type
of information was presented.
A classification and description was given of the information presented on the
linked page with its category heading, (e.g. patient narratives under the home page
category o f research and development).
For the homepages, certain clusters were established: company history, drug
information, investor relations, research and development, other. ’’Clustering" is a
general name given to the process of using and/or forming categories, and the iterative
sorting o f things-events, actors, processes, setting, sites-into those categories (Miles &
Huberman, 1984).
The company sites and their presented information were clustered in a way that
addressed the functional research questions: surveillance, correlation, socialization,
entertainment, and manipulation.
Gathering information for the magazines was done for each issue for the
month o f May and was collected from the selected magazines at the end o f the
month. Each issue of each publication was searched by hand to find drug
advertisements. O f any ads found, they were labeled by date, product name,
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company name, publication title, and if a website address was given. A photocopy
was made of each ad.
A key element was whether or not the magazine ads had a website address. If a
website address was given, the researcher went to that specific website and recorded any
o f the differences and similarities between the magazine ad and the website information.
This information was compared to the information that has been presented on the
selected pharmaceutical company Webster. Any differences or similarities were
recorded.
Coding
Copies were made of the relevant material. All printed material was kept in a
notebook. Once all the material was collected, a detailed description o f the magazine
ads and six Web sites was written. The content was organized into categories based on
the research questions. Illustrative examples were presented to explain the items from
each category, and tables were utilized to present the information in an organized,
summary manner.
Interpretations
Inductive reasoning is the logical model in which general principles are
developed from specific observations (Babbie, 1995). Qualitative interpretations
result from the intensive analysis of a single case, or a few cases. The intimate
knowledge gained o f subcultures and organizations is written up in a way that
discloses the author's insight. For interpretative science, meanings arise out of
the intentions, practical purposes, and the reciprocal perspectives. This scope of

analysis is called ideographic. One does generalize in qualitative research, but
not in a way that tries to obtain the scope of a universal law. Instead, the
richness o f the particular elements that are documented and the patterns or
themes they exhibit allow the researcher to generalize to other cases o f the same
problem in the larger culture. It is not intended to explain a universal, ahistorical
mechanism for behavior (Lindlof, 1995).
After this part o f the study was completed, the interpretative method o f subsuming
particulars into the general was done. Subsuming particulars into more general classes is a
conceptual and theoretical activity in which the analyst shuttles back and forth between firstlevel data and more general categories (i.e. information on the websites and the broader cluster)
which evolve and develop through successive iterations until the category is "saturated" (new
data do not add to the meaning of the general category) (Miles & Huberman, 1984).

Chapter 4
RESULTS

Due to the large amount of information gathered from the six Web sites, the
results were broken down into several categories based on the framework of the research
questions. The first section describes the homepages of the Web sites. These pages
alone deserve specific attention because they are the first pages users are exposed to
when accessing the sites. The homepages all contained the same categories for linking
options but under different names. The categories are as follows: company history, drug
information, investor relations, research and development, other. After the findings of
the categories have been reported, the type of information that is presented will be
assessed. This information will be associated within the following functional categories:
surveillance, correlation, and socialization and entertainment.

Home Pages: An Overview of Links

Merck (fig. 1) had its menu options on every linked page as it is presented on its home
page. The menu items are: Site Map,News Products, Publications, Research, About Us,
Topics fo r Health Care Pros and In Your Country.
Lilly (fig. 2) had menu options of: Who We Are, Targeted Disease Categories,Message
from the Chairman, Strategic Focus, Financial Information, Press Releases, Corporate
Citizenship, Speeches, Career Opportunities and Contact Information.
Pfizer (fig. 3) had a case scenario page that is presented before the actual home page is
presented. The menu items are: Keeping People Well, Keeping Animals Well, Research
and Development, About Pfizer, Investing in Pfizer and Career Opportunities.
BM S (fig. 4) had the menu options of: Latest News, Core Businesses, For Our
Customers, For Our Investors, Media Connection, Message From the Chairman, A
Look at BMS and Employment Opportunities.
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Schering Plough’s (fig 5) menu options were: Allergy Zone, Skin Cancer Zone,
H epatitis Zone, ToughActin’ Tinactin, Research Zone, Schering Plough Zone, Anim al
Health Zone, Cold Sore Zone and Prostate Cancer Zone.
Ciba, now Novartis, (fig. 6) (See Appendix B for further explanation). Who We Are,
Health Care, Agribusiness, Nutrition, Investors, Media, Contact Us.
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Copyright <Q 1994.1997 Eli r.illv and Company. Lilly Corporate Center, Indianapolis, Indiana 462*5 USA. All rights reserved.
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* New on the site
* You're As Young As You Feel Allowing people to mature with
greater vitality and fewer medical costs
is more important than ever.
* 1997 Pfizer Annual Shareholders'
Meeting Report
<• Pediatrics & HIV: New Link - Pfizer
is co-sponsoring this edition o f "The
Cutting Edge Medical Report",
premiering July 17 on the Discovery
Channel.
<• American Medical Systems - a world
leader in implantable medical devices
to treat impotence, incontinence,
urethral strictures and BPH.
* Get In Step With Howmedica - Tour
the innovative products and programs
from a global leader in orthopaedic
implant technology

hie products discussed herein m ay have different
product labeling in different countries. The product
information provided in this site is intended only for
residents o f the United States.

keeping people well j keeping animals well | research and developm ent | about
pfizer
investing in pfizer | career opportunities | search | site map
C o p y rig h t €> 1996. 1997 Pfizer Inc. All rights reserved.
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The three-week study revealed that the websites changed very little other than
minor variations o f highlights on certain company home pages. For example, the Merck
site had changed only with highlights presented on its home page that simply was a
rotation o f already presented material. In another instance, the update for ScheringPlough’s home page was dated April 3, 1997 and was not updated again during the
course of the study.
There is a vast quantity o f information presented by these companies that ranged
from investor relations to personal testimonials. However, the majority of the
information was PR-friendly text. Specific brands of pharmaceuticals were a rarity, and
when they were presented, the information was limited by a physician DEA (this is a
license the Drug Enforcement Agency approves for physicians to dispense medication)
code block or there were simply no other links. Most company websites gave general
information about certain diseases, symptoms to look for and other related material, but
very few actually "advertised" their products. Product names were given, as an example,
Lilly’s Humalog was presented on its “managing your diabetes” link, but there was no
continuation of that specific product other than a small graphic with the product name.
There was no link to more information about that product. Other links simply gave
overviews of diabetes, and when there was a hypertext link option, it simply went back
to the original link page with the small graphic and product name o f Humalog.
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Another example o f this lack o f true advertising was the presentation o f a specific
product followed by technical jargon that one could argue to be for physicians or
pharmacists rather than a lay consumer. An example o f this would be with Merck’s
Comvax link which in a press release gave a date and product name without stating what
the function of the drug was other than, “Comvax, haemophilus b conjugate
meningococcal protein conjugate.”
Surveillance Function
The first research question asked: What type o f information was presented? Did
it inform the viewer? Did it provide news? The very essence o f the websites was
information based. All of them gave information about their company. However, the
vast majority of the websites did not give information on pharmaceuticals. Although all
o f the companies posted a plethora o f information, very little had anything to do with
drugs. Brand names were prevalent in some o f the sites, but more detailed information
for the products were not found. The information that was given ranged from stock
quotes to press releases. Ciba/Novartis’ had a press release from May 13th in regards to a
business acquisition.
Basel, 13, May 1997-Novartis announced today the acquisition of Merck & Co.,
Inc.’s (located in Whitehouse Station, New Jersey) Crop Protection business for
a price o f USD 910 million. The deal includes the worldwide right to Merck’s
business, which had 1996 sales o f USD 200 million with strong position in the
high-value acaricide/insecticide and post-harvest fungicide markets. Also
included are approximately USD 21 million in product inventories. Novartis has
entered into a long-term supply agreement but will not be acquiring any of
Merck’s manufacturing plants.

Merck also had a menu option o f news. This site contained similar items as the
other websites and their press release material. Again, as with other aspects of the
websites, the information given in these press releases dealt more with business ventures
than with actual drug products. Lilly’s press releases link was categorized by month for
this year. Link one was to April 21st and showed the first quarter sales growth. The
second link was to a May 29th (fig. 7) press release that is fairly typical of the other
website formats. The press release deals with funding and research incentives.
Outside news sources were evident in a few of the company sites. BMS had
media connection with one link to press releases. This one link had many menu items
and latest press release information (April 29th, 1997). Other linked items were to
entirely different subject/topic areas such as. news, industry focus, on line magazines,
etc. This was an outside service that posted BMS's information. This service was called
PR NEWSWIRE, a separate entity.
All of the sites had business information. The information ranged from stock
prices to annual reports. Figure 8 shows the BMS link that had up-to-the-minute stock
information that was fairly typical o f the other websites. Merck was typical o f the other
websites as it had an annual report. This screen had a mission statement link, investor
relations and financial news. Under investor relations and financial news there were four
more menu options. These were: corporate information, stock price, FAQ’s and
financial news. The stock price also was given. It had the current DJIA price with an
economic graph. This section also asked for your win/loss record with Merck stock.

Press Release
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Mav 29. 1997
(317) 276-5795

M illennium BioTherapeutics and L illy Enter Into a Collaboration
To Develop and Com m ercialize Therapeutic Proteins
Millennium BioTherapeutics, a New Subsidiary o f Millennium Pharmaceuticals, Enters First Major
Pharmaceutical Alliance
Eli Lilly and Company (NYSE: LLY) and Millennium BioTherapeutics, Inc. (MBIO), a newly fonned
subsidiary of Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM), announced today that they have
entered into a collaboration for the discovery and development of novel therapeutic proteins. The alliance
with Lilly is the first with a major pharmaceutical company.
The agreement covers a three-year program with Lilly providing S8 to $10 million m research funding per
year with a provision to extend up to an additional two years at the same level of funding. Additional
licensing fees, clinical development milestones and royalties will be payable by Lilly in connection with
specific therapeutic protein product candidates identified in the collaboration and licensed by Lilly- Lilly
has also agreed to mwlre a $20 million equity investment in exchange for 18 percent of the issued and
outstanding shares of MBIO.
"Millennium Pharmaceuticals formed Millennium BioTherapeutics as a subsidiary to establish a focused,
ftnmpl«nmnt«fy effort capable of realizing for our shareholders the maximum value inherent in
Millennium’s commercial opportunities in biotherapeutic products.” said Steven Holt/man, chief business
officer of Millennium Pharmaceuticals. ’Launching Millennium BioTherapeutics via this uniquely
structured alliance with Lilly, a co m p a n y with whom Millennium currently enjoys two other
collaborations, represents a major step toward realizing this goal.”
Under the terms of the agreement, MBIO and Lilly will equally fend the collaborative program to
discover and define the therapeutic utility of candidate therapeutic proteins. The collaborative research
will create a pool of potential protein drugs that have defined therapeutic utility in in vivo models. Each
company will have equal rights to select candidate therapeutic proteins from the pool for its exclusive
development and cnmmpTCialiVahno- Both companies will share the right to use discoveries mnWe in the
collaboration for the purposes of developing small molecule drugs. Millennium BioTherapeutics retains
the exclusive right to use discoveries made in the collaboration for all other purposes, including to develop
antibody therapy, gene therapy and antisense products. MBIO has transferred small molecule drug and
predictive medicine rights to Millennium Pharmaceuticals.
"Lilly I**3 significantly enhanced its therapeutic protein discovery efforts with this important collaboration
that will focus on the identification and validation of novel proteins,"
August M Watanabe, M D ,
executive vice president, science and technology for Lilly. "A genomics-based therapeutic protein
discovery effort is a critical component of our commitment to maintaining our leadership position in
therapeutic proteins."
We are delighted to have Lilly, a world leader in the development, mannfiw-tnring anHmadr-ting 0f
biotechnology products, as a therapeutic protein partner," noted John Maraganore, Ph n vice president
and general manager of Millennium BioTherapeutics. "We are confident that Lilly's extensive research
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Figure #8

In addition to this, outside investor resources were also linked to the company sites.
Ciba had investors link, which gave a long list o f investor relations’ contacts and stock
information. Link one was to Novaritus stock that in turn linked to an outside
program/server and hit the stock list in the £CN” section for Novaritus. Link two was to
key dates, and this gave dates o f various meetings, however, there were no locations or
contacts. There were no links from this site. Lilly’s site also had financial information
that gave annual reports, stock prices, and quarterly earnings releases. The first link was
stock price, and there was a disclaimer as the server exited the Lilly website and linked
to the Quicken Financial site. The second link was to the (most current) 1995 Annual
Report. This information was introduced with the scenario of a girl with a disease that
had been helped by Lilly’s products
Business descriptions o f the companies were given on many of the websites.
BMS’ core businesses had the menu options of: consumer products, medical devices,
nutritional, and pharmaceuticals. Link one was to consumer products which
automatically went to another menu screen where EXCEDRIN and other OTC products
were displayed. These items were not linked to other pages. Detailed information about
the products themselves were not given other than graphic representation. Link two was
pharmaceuticals. This site had two menu options: pharmaceutical research institute and
therapeutic areas. No drugs were displayed on either site only BMS’ research facility
and their established procedures.
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Correlation Function
The second research question asked: What was the correlative nature of the
information? What was the editorial content? Was it educational, promotional, or
otherwise? Most o f the websites were a combination o f educational and promotional
material. The information that was presented would most o f the time be designated in a
educational/informational manner. Most o f the websites would go into detail about
ailments for illnesses, while espousing their corporate commitment to medical excellence.
Again, the majority of the websites did not have product specific promotions. Yet there
were instances where the “educational” forums would be sponsored by a specific
drug/product. An example o f this would be Schering’s Allergy Zone that featured
Claritin. The site gave information on allergies and symptoms o f allergies, with a Claritin
logo on each link.
Promotional efforts included Merck’s Mediquiz (fig. 9) which offered browsers a
free T-shirt. Four categories were presented: your body, medical discoveries, what’s in a
name, and featured topic. Under medical discoveries, five questions were given. They
were multiple choice on various topics, (i.e. when was the first Cesarean section
performed?). Merck also had the disease information park. This option gave the link
choices of heart disease, preventable disease, HIV/AIDS, glaucoma, and osteoporosis.
The first link explored was heart disease. This link gave various background information
on the disease, (i.e. you can quit smoking) and other elements for disease prevention.
Brand names of Merck’s pharmaceuticals were not mentioned however. The second link
was surviving high cholesterol with a full motion video that could be ordered. (It is the

Independence Day (USA). Canada Day. President's Day
(Botswana). Simon Bolivar Day (Ecuador and Venezuela). The
Day of the Sea (Japan).
July is full of holidays all over the world. While a web site can't
hope to match such ceremony and celebration, we mark the month
with another round of Merck's popular trivia feature, MedlQuiz!
Don't be timid; you might know more than you think. Find out by
taking our quiz, and you could win a T-shirt!
The multiple-choice quiz features five questions in each of four
categories. Every month the first 10 winners who submit their
contact information will be eligible to receive a
[free T-shirt. Even if you don't win, you still come
out ahead with a store of fascinating facts, terrific
tidbits, and just plain useful information.
s h ir t !

N ow grab your virtual lab coat and stethoscope,
and click on one o f the following four categories.
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same as the ad that may be seen on TV that shows white on black text for synonyms of
heart disease, with the phrases of “artery goo,” “blood mud,” etc). Promotional material
could be found with the research item which showed published scientific work, Merck
scientists available for seminar presentations, Merck gene index, MRL (Merck Research
Labs), and career opportunities. Link one had published science. This was filled with
medical jargon. Link two had available speakers and gave names, summary o f studies
and addresses only. What was unclear was whether or not the speakers were available
for hire.
Lilly also had correlative elements. Targeted disease categories had several link
options with: CNS, endocrine, infectious, cancer, cardiovascular and diabetes. Diabetes
was the only link option active (fig. 10). Link two was to the education center. This site
had long menu items ranging from glossary, to caring for your feet all in regards to
diabetes. All gave the option for medical questions to be written in and sent via e-mail.
Pfizer had keeping people well with various menu links: dealing with depression,
and the allergy information center (which is divided by product information and
educational sites). Link one was the allergy information center that had the menu items
o f information, games, pollen count, and a survey. “Zyrtec” (fig. 11) was the featured
product that the site was built around. Link two had the survey with a disclaimer. The
function of this option was typical o f many of the websites in that they combined
educational/informational material in the context of the company, (or in some instances)
the product name.

D iabetes inform ation for health care professionals, patients, and
consum ers in the US only.

Figure #10
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Figure #11

How are your allergy symptoms today?
severe
bad
pretty bad
slight
none
During which season (or seasons) do your allergy
symptoms bother you?
spring
summer
fa ll

winter
What are you allergic to?
Grasses
Molds
Trees

As for promotional material, there was basically PR friendly text on company
history. Ciba had for example, a health care link virtually the same menu items as did the
homepage and the who we are link. Link one was to consumer health that was a
synopsis of PR information. BMS had similar information with message from the
chairman, which had no links and gave some PR friendly text about the company. Ciba
had promotional material that was on a company wide level. This sort of information
was typical of all of the companies involved in the study.
As one of the world’s leading life sciences companies, Novartis is dedicated to
creating value for its customers in the areas o f Healthcare, Agriculture and
Nutrition. Our commitment to health, safety and the environment (HSE) is part
of this dedication and is inseparable from our activities, our identity and our
values. Excellence in health, safety and the environment is not at odds with, but
is rather intimately connected to our goal of providing the world with innovative
products.

BMS had the company profile site. This site gave varied information such as
general statistics of the company, earnings, and the number of employees, etc. Lilly had
message from the chairman which simply showed the picture of the CEO and presented
some PR friendly text. Lilly also had corporate citizenship (fig. 12). This menu item had
many link options with: community, global philanthropy, and environment. Link one
was global philanthropy. This link presented text regarding a $66 million philanthropic
PR piece that had a link to a financial information option. Link two was the financial
information link. This had various menu items ranging from grant guidelines to
employee directed giving. As was common with all of the websites, drug specific

T

he belief that private enterprise has a special
responsibility to contribute to the progress of
society has been basic to the philosophy of Eli
Lilly and Company throughout its history. This
belief is a legacy of the Lilly family, who founded
and led the company, and Lilly employees, who,
for more than a century, have traditionally
supported nonprofit organizations that help
strengthen the fabric and enrich the quality of life
of communities and nations. Through financial
grants, the donations of products and equipment,
and the volunteer time and expertise of its
employees, Lilly offers assistance to organizations
whose programs help meet the needs of people in
the areas of health and human services, education,
civic affairs, and culture. Its product donations
provide ongoing support to the developing world.
The company also contributes to disaster relief
efforts. The commitment to good corporate
citizenship reflects the fundamental concern of the
company and its foundation for the well-being of
people and the quality of life. It is a way to share
Lilly's success, to invest in the future, and to give
back to society. It is an integral part of the
company's mission.
In 1996, Lilly contributed more than $66 million
in cash and product valued at net-wholesale price
to charitable organizations around the world and
joined the circle of companies in America with the
most generous records of giving.
F I N A N C I A L IN F O R M A T IO N
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promotions were not prevalent. Promotional and educational material was on a macro
level in that it dealt with the company or the industry as a whole.
Socialization Function
The third research question asked: Did the information provided act as
socialization? Did it communicate values and norms? Granted, this is a bit more
subjective in nature and does ask for some interpretation by the researcher, but there are
instances o f both cases. For example, Merck has in your country with links to different
countries: Canada, Japan (fig. 13) and Italy. For example, the link to Canada, had
English and French language options. Link two was the English option. This had
additional menus with different options, quizzes, patent legislation, etc. Lilly was even
more culture specific with who we are gave a company overview with linked options
ranging from the history o f the company to major facilities. The site showed the history
o f the company and general background with dates and locations. Other sites listed
many countries. As Merck’s site had Japanese language, one o f the company sites had
Italy as an actual link and when explored further, the site was discovered to be in the
Italian language. The transmission o f the companies onto the worldwide stage was
evident in much o f the information given in the sites. Most o f these companies are global
in their capacities. Almost all o f the literature have each o f the companies describing
themselves as, “global research-based,” “world leader in life sciences,” or some other
similar capacity.
Schering had two options that transmitted the norms o f individuals wanting to fit
in with society. Cold sore zone is a site that had brand names with graphics. “Viractin”
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brand name was the one link option. Link one was Viractin, and this link presented a
narrative of a self-conscious individual with a cold sore.
That person is staring at my lip...or at least it seems that way. When you have a
cold sore, it feels like the whole world is looking at the throbbing blister on your
mouth. It’s no wonder that cold sores seem to hurt your ego as much as your
lips.

The Prostate cancer zone had the linking options: patient information directory,
professional information (which is password protected), and Schering patient support
programs. The Schering patient support group gave various scenarios and the browser
could order certain videotaped programs. The website transmitted the value of
community, in that prostate sufferers would know that there were other men like them,
and Schering was concerned about their health. An example o f this was the video,
“Committed to Life” and this had a brand name link to “Eulexin” which went to
prescribing information about this specific product that one would find in printed form
when a prescription drug was prescribed. The researcher was unable to view the
videotape at the time.
Another value that the websites transmitted was by playing upon the booming
U.S. economy. The option/opportunity for working in the pharmaceutical industry was
prevalent in almost all o f the company website. Lilly had a summer intern program (fig.
14). BMS had an employment opportunities site with many menu items that were for
specific positions, (i.e. manager of strategic procurement management positions, etc.)
Link one was to the manager o f strategic procurement management position; this gave
the details o f the position and the requirements for consideration for the job. Link two
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Figure #14

THE
FITTING
ROOM
The Fitting Room -- that little space of horrors
where new life forms are discovered under
unforgiving fluorescent lights. Don't despair.
Help is on the way.
Dorothy. Women's Link fitting
room attendant, will help you match
your body type with the right
clothing styles to bring out your
true star material.
Y ou may already know what
styles of clothing bring out your
best features and hide your least
favorite endowments. If you
have a generous bustline, you
know that a bumblebee t-shirt
with horizontal stripes will
make you look wider and
shorter. And that black and dark
colors make you look smaller or thinner and
white and light colored clothing enlarges your
overall look.
B ut there's much more to know!. As you
navigate The Fitting Room with Dorothy, you'll
learn how to best define your body type or types
and how to choose clothing styles to help you
look and feel your best. Plus Dorothy will fill
you in on what styles to avoid and what to do
about those " special features" you may want to
downplay.
START BY SELECTING YOUR
BODY TYPE
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was in examining another o f the positions. This was for associate counsel, and again, it
listed similar things as the other positions offered. Schering also had similar options
with its research zone. This had several menu options with R+D, career opportunities,

news, about Schering Plough and e-mail. Link one was to career opportunities with the
menu items of: current opportunities, rewards and recognitions, and benefits. Career
opportunities ranged from guidelines for submitting your resume to benefits.
Entertainment Function
The fourth research question asked: Did the information have an entertainment
value? Most of the websites were straightforward in their presentations o f the
information. Among all of the company websites there were no specifically designed
entertainment items. Some sites had quizzes and games, other sites simply had fun
theme graphics, like Merck's balloons. However, some o f the websites (in the minority)
did have some entertainment functions. For example, BMS had a site for the sole
purpose o f entertainment; Women’s Link, which is BMS’ Clairol Web site. This site had
a mall display and had such options as FAQ’s and product information. Another feature
that was connected to Women’s Link was the fitting room (fig. 15). This site gave
recommendations for the most flattering way to dress.
Schering's the skin cancer zone had the links of: about skin cancer, about sun
safety, and about treatment. Link one was to sun safety. This link gave menu items to
other links, (i.e. UV index, important contacts). Link two was to important contacts.
Address and number for the Center for Disease Control and the National Weather line
were given.

The Lilly Summer Internship Program
At Eli Lilly and Company, we began our summer intern program more than 40 years ago and believe
that we have one of the best in the country. Our internship selections for 1997 are complete, but we
encourage you to visit our booth at campus job and recruitment fairs to explore the possibilities for a
summer '98 internship.
We offer:
Challenging summer projects that provide opportunities to become actively involved in issues
critical to our company. The projects are designed to utilize and develop the intem's talents and
knowledge, as well as the leadership and communication skills essential to a successful career at
Lilly. Students are exposed to all levels of management and usually present the results of their
projects to top executives.
Interaction with other interns and many Lilly employees both on and off the job. For example,
Lilly locates reasonably-priced, furnished housing so that all interns can get to know each other by
living in the same area. Also, many social activities are planned throughout the summer to
encourage informal interaction with other interns and Lilly employees.
Please see instructions on submitting vour resume.
See also information on internships in Elanco Animal Health.

Eli Lilly and Company is an equal opportunity employer.

TIndiana Employment Opportunities Index ]
THome I Search I Feedback 1
C opyright O 1997 Eli Lilly and Company

Figure #15

ToughActin' Tinactin option is of course a brand name OTC product. This site had John
Madden with Jocks in a work out room. One o f the options from this site was for fun
and games (fig. 16). This gave two trivia questions where the browser could guess and
then send the answers via e-mail and if they got the answer right and were picked from a
drawing, the participant could win $50. None o f the other websites had any similar
entertainment items. Some had quizzes, like Merck’s for its T-shirt, and others simply
had short quizzes with basic medical questions:
Which is the longest nerve in the body?
a.
b.
c.

optic nerve
sciatic nerve
spinal cord

Manipulation Function
The fifth research question: Was the information used for manipulation? As the
literature review has shown, pharmaceutical companies have been under attack for
disseminating false and misleading information. The information in the websites can not
be held up to scrutiny at this time, yet the information that does appear on the websites is
most favorable to the companies and their products.
The Schering Plough zone site may be considered the home page, but the
corporate information listed “Myhealth” as the home page. In addition to a confusing
web address, Schering had a manipulative angle in its presentation of the hepatitis zone
(see figs. 17,18) this option gave various menu icon items that range from understanding
your liver to upcoming symposia. This might have been misconstrued in determining
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Figure #16
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Welcome to the Health Care Homepage!

News

- Last updated 4/3/97

Schering Plough Research division now on line!
r C heck out the A llergy A lert for vour area in the C laritin Zone
r

C heck out the Cold Sore Z one for vour lip needs!
N ew Sym posia A nnouncem ents in H epatitis Zone
C laritin is A Logical A lternative to Seldane
P rofessional Inform ation section now open in the Claritin Allergy R elief Zone

•" V isit The International D ivisions o f Schering Plough
- Professional Inform ation section now open in Skin_Cancer Zone

Welcome to the Health Care Homepage, brought to you by Schering-Plough.

Five Million Americans have Hepatitis. Do You?
F iv e m illio n
A m e r ic a n s h a v e

w• v m

^ 8 0 0 -2 2 3 -0 1 7 9

The hepatitis B and C viruses are more common and can be more infectious than the
AIDS virus. Yellowing of the skin or eyes can signal hepatitis B and C, although most
people have no recognizable signs or symptoms. Untreated, hepatitis can lead to scarring
of the liver or even liver cancer. You are at risk for hepatitis if you have been exposed to
infected blood or body fluids through tattooing, body piercing or sharing razors or
toothbrushes. Unprotected sex with many partners or experimentation with illicit
intravenous drugs also puts you at high risk. Your doctor can do specific tests to
diagnose hepatitis B and C. Get tested. In many cases, hepatitis can be treated.

GET TESTED
If you suspect you are at risk, see your doctor or call the AMERICANLIVER FOUNDATION for
free information.

1-800-223-0179
GETTING HIP TO HEP
WHAT EVERY HEPATITIS PATIENT NEEDSJOJOVOW
UNDERSTANDING YOUR LIVER
RED BLOODED BLUES
PRESS RELEASES
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what company is responsible for the startling image o f a child’s blue face and yellow eyes
(the only two colors in the website). The magazine ad is the same as Schering’s web
link. Yet the magazine ad is sponsored by the liver foundation (fig. 19). It was
confusing in determining who was responsible for the ad. Pfizer had a few manipulative
elements in its website as well. To begin with, when the hompage was initially
connected, there is a brief teasing testimonial before the actual homepage is brought up.
“I was 25 and could barely move. What kind o f life was I going to have?” (fig. 20).
After this screen was flashed to the viewer for a moment, the homepage appears. Pfizer
had a menu option of testimonials and this picture of this woman was among the options.
What could be questioned is whether or not such testimonials are really true. It is not in
the context o f this study to determine.
Pfizer constructed another manipulation o f information. One option was for
“The contribution o f pharmaceutical companies: what’s at stake for America.” There are
22 pages that follow this option which traces the history of the pharmaceutical industry
and the political ramifications and conditions o f operating under the regulation o f the
U.S. government.

Viewed from a long perspective, progress in health care has been one o f the great
successes of the twentieth century. This fact should be one o f the premises o f the
current debate on health care reform. At this point it is not.. .there is no scientific
way to place a dollar value on extending human life and improving its quality, or
to measure what percentage o f this extension is due to drugs. However, the
value that each person would place on extending his or her own life expectancy
from 54 to 75-21 years-is surely substantial.

B S W i ii w w
hepatitis C th is y ear alone, a n d w ithin th e n e x t 10 to .20 years th a t numbe r is
expected to triple. if you received blood befarelM O . either during a medical p r e c e d i n g ;
a s a medical treatm ent you are a t risk for hepatitis C Unprotected sex with nrany partnets;^>.
o r th e use of illicit intravenous or intranasaldndjs can place y o u a t greater rak for d evelop +*.-;■
ing hepatitis C lndivtduals in occupations w hereexpasure to blood can occur^uch as h e a th
care workers/emergency medical technicians a n d paramedics, may b eath ig h errisk for: -

- c h ro n ic

Figure # 1 9
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I
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" g e t t e t e d In many cases; fiepatitis.C can be treated effec^ --~ tivety. If y o u iuspect you. are a t risk. see your doctor or call -:.--;.
’ the AMERICAN LIVER FOUNDATION for free in f o r m a tio n .- ^

m G rM JC * t

i

Amertcon liver.

1-888-4HEP-USA -

Foundation
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www.Hverfoundation.org

t

"I was 25 and could barely move.
What kind of life was I going to
have?"’
Melinda Sheppard
Nantucket, Massachusetts
Today Melinda is avid about her aerobics. But eight
years ago, she could hardly walk.
Pains that started in her left foot spread to her hips,
wrists and ankles.
The problem was chronic inflammation of the joints.
Thanks to physical therapy and medicine developed
by Pfizer research, Melinda’s active life returned.
And shortly thereafter, so did her smile.
We're part of the cure.
Copyright €> 1996. 1997 Pfizer Inc. AH rights reserved

Figure #20
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The manipulation o f information also occurred when websites inquired about
specific individual information. Schering’s allergy zone menu options had mailing list
information. Link 2 was to the mailing list. This link mentioned the product name
“Claritin” and gave a survey for demographic/mailing information for the browser to put
into the given space. Another way in manipulating the information was through
restricting access to certain information. Schering had a link to the health care
professional. Password only or the DEA (Drug Enforcement Agency) number for
physicians to access this link could only access this link.
Magazines
As for the magazine ads, similar themes emerged. M odem Maturity (fig. 21) is a
bi-monthly publication. May/June was the issue used for the research. There were no
pharmaceutical advertisements. However, there were a few o f the same ads for the
AARP pharmacy service. This evidently is a service provided by the Agency for the
Advancement o f Retired People that does cost comparisons among drug manufacturers
;
for the least expensive drugs. Three brand names of presumably the same compound are
compared on a chart: Lescol, Zocar, Pravachol. There is no further explanation as to the
make-up or function of the drugs, so perhaps it is assumed that the target audience is
familiar with the drugs. No website address was given.
The mainstream magazines have a different result than the highly targeted
publication. Time and Newsweek both have prescription drug advertising in their issues
for the month o f May. For the month four issues were examined. The dates are the
same for both publications: May 5th, 12th, 19th, and 26th. There were no pharmaceutical

in ow you can reel better

even before you take
your medicine.
Lescol

20mg*60ccpiules

Zocor

Pravachol

20mg*60tablets

20mg*60 tablets

PharrridcyG<

AARP P tu m u c y Service called one pharm acy from a m ajor chain in each o f the four cities m entioned above on 1/23/97 - 1/ 24/ 97. T he prices shown are actual prices
o n d u r dale. Prices m ay vary daily and from pharmacy to pharmacy. AARP Pharm acy Service's prices are valid nationally for the drugs shown until 7/ 31/ 9 7 .

As you can see fro m th e chartabove, o n e o f th e th in g s we
d o at A ARP P h arm acy Service
is m ak e sure you d o n ’t have to
pay m o re than y o u need to
for th e m ed icatio n s you need.
W e c arry over 3 ,0 0 0 b ran d
nam e a n d generic p rescrip 

tio n d ru g s as well as a c o m 
plete line o f n o n -p re sc rip tio n
health p ro d u c ts th at are all
c o m p etitiv ely priced . We also
have a 7 -d ay -a-w eek p h o n e

to fill your p rescrip tio n s safe
ly and answ er y o u r q u estio n s.

serv ice t h a t ’s a n sw e re d by
frien d ly a n d k n o w led g eab le

Even fast an d reliable delivery
by mail that com es stra ig h t to
your door. For over 35 years,
w e’ve h elp ed m illio n s o f
AARP m em bers feel better.

people. A sta ff o f ph arm acists

W e’d like to help you too.

To get your free price quote, call

1-800-456-7821 . Ask for Department 112130

M o n d a y - S atu rd ay , 6 a m to 1 0 p m & S u n d a y , 8 a m to i f i g U f e # 2 1

A4RP PHARMACY
ZZ&ZZSERyiCE
fro m RETIRED PERSONS SERVICES, Inc.
Reared Persons Services, Inc, which administers the AARP Pharmacy Service, is a separate ax-panag

e n a ty

not owned or coocroUed by AARP
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ads in Newsweek’s May 12th edition. The breakdown o f the data was by publication and
date.
Surveillance Function
The first research question asked: what type o f information was presented? Did
it inform the viewer? Did it provide news? Most o f the magazine advertisements gave
information and informed the reader. All ads had the subsequent FDA label information.
All of the magazine ads presented vast amount o f information ( fig. 22) as they are
required by law to do so. The information was the labeling risk information that the
ID A requires. In this regard all o f the ads provided information, even more so than the
websites. However, due to obvious space restrictions the websites gave a much more
vast array o f information than the magazine ads.
Other types of information ranged from news to directions for use. Time’s May
19th issue had an ad for “Caveiject alprostadil for Impotence.” The ad was mostly text
with the headline, “Impotence. If your treatment hasn’t made the difference you
need...maybe you need a different treatment." The ad continued with the text:
When properly dosed, Caveiject produces an erection that lasts about one hour.
So if your aren’t satisfied with your current impotence treatment, or if you
though impotence couldn’t be treated at all, caveiject could be the answer. Many
insurance plans, including Medicaid, will cover it.

In addition to this information, the ad gave safety information and quasidirections for use. “It simply takes about 10 seconds to self-inject Caveiject into the side
o f the penis. This puts the medicine right where you need it. Once the ideal amount has
been established, the erection usually lasts about one hour.” The company is Pharmacia
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& Upjohn, and their name was mentioned in the ad. No website address was given,
however a 1-800 number was present for more information.
Correlation Function
The second research question asked: what was the correlative nature of the
information? What was the editorial content? Was it educational, promotional, or
otherwise? Most of the magazine ads were promotional in nature. Some could be
considered educational simply by the specific information they gave. The magazine ads
differed from the websites in that they specifically promoted a specific pharmaceutical
product, whereas the websites tended not to. The May 26th edition of Newsweek had an
ad that was for “Accolate zafirlukast.” The headline was "accolate twice a day helps me
control my asthma." The ad had a picture o f a young woman and her puppy. The
company is Zeneca. The company name was not prominent. There was no website
address. There were promotional and educational components of this ad which were
typical o f most o f the magazine ads. The promotional piece was with the selling point o f
the convenience o f a tablet. “You know how frequently you have to use your rescue
inhaler. By making Accolate part o f your asthma treatment regimen, you may even
reduce your reliance on your inhaler. With Accolate, you simply take one tablet in the
morning, another in the evening.” The educational element was in the citation o f medical
studies. “Accolate has been shown to have a side-effect profile comparable to placebo
(sugar pills). In fact, in over 4,000 people studied, Accolate was generally well
tolerated.”
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Socialization Function
The third research question was: did the information provided act as a transmitter
of culture? Did it communicate values and norms? The magazine ads were all in the
English language, so there was no other foreign influences or options as there were in
the websites. Therefore culture was not communicated. However, values and norms
were communicated. Much like the Schering’ cold sore zone playing upon and
individual’s vanity, there were a few magazines ads which did likewise. The May 19th
edition o f Newsweek had an ad for “metrogel/metrocream metronidazole topical,” with
the headline, "Maybe its sunburn. Maybe it's skin irritation. Maybe it’s an allergy.
Maybe its acne. Maybe its Rosacea." In another ad there was a picture o f a woman's
face with discoloration (fig. 23). The product is from Galderma Labs. The company
name was not prominent. No website address was given. Time's May 19th issue had an
ad for “denavir penciclovir” for cold sores. The ad showed a self-conscious woman
holding her lip with the headline, “new prescription Denavir blocks the virus in the cold
sore, so it heals in 2-4 days.” The company is Merck. Their name was not in the ad. No
website address was given.
Entertainment Function
The fourth research question asked: Did the information have an entertainment
value? None o f the magazine ads had sheer entertainment functions as did some o f the
websites. None o f the magazine ads had quizzes, or games for the viewer to participate
in. However, some o f the print ads could be considered “entertaining” as they were
presented with a lighter flair and a more humorous angle. An example o f this is the May
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MAYBE IT’S AN ALU
MAYBE IT’S ACNE.

ftrsistent redness or flushing in the middle areas of the
face. Broken blood vessels. Acne-like bumps. These are
all symptoms of rosacea— a skin condition that affects
over 12 million Americans middle-aged and older.
Rosacea symptoms may come and go, but without treat
ment, they may get worse over time. Over-the-counter
medications may help temporanly, but to really get your
rosacea under control, you need to see a doctor.

MetroGel.I MetroCream'

(metronidazole topical gel) / (metronidazole topical cream)
Topical Bel, 0.75% I Topical Cream, 0.75%

R o s a c e a th e ra p y t h a t w o rk s .

So don’t wait. Talk to a derm atologist today. And
when you do, ask about MetroCream™ or MetroGel®
the #1 doctor prescribed topical rosacea medication.

FOR FREE INFORMATION
ABOUT ROSACEA,

In clinical trials, patients expenenced the following individual
side effects in order of frequency: skin discomfort (burning
and stinging), redness, skin irritation, itching, or worsening of
rosacea. The total incidence of side effects was approximately 10%.

CALL 1-800-432-4909
CGaWBrmaLafcoraww,Inc1996. Plec se»nanpag»tormoortamproductrtmmaicn.

19th edition o f Newsweek had an ad Atrovent ipratropium bromide with the headline,
"break free from your runny nose" and a picture with a play on ball-and-chain with a box
o f tissues (fig. 24). The company is Upjohn. The name was not prominent. No website
address was given. The Newsweek ’s May 5th edition was a cartoon ad for “prilosec
omeprazole” (fig. 25). The ad showed a cartoon man holding his stomach. The headline
is, "If your heartburn medicine works so well, why do your keep getting heartburn?"
The manufacturer is Astra Merck. The company name was not prominent. No website
address was given.
Manipulation Function
The fifth research question asked: Was the information used for manipulation?
As with the websites and some o f the examples of manipulation, the magazine ads could
have had information that was not entirely accurate. Aside from this possibility is the
fact that some o f the ads did play upon or manipulate the emotions. Newsweek’'s May 5th
issue had an ad for “rimadyl carprofen,” an animal product that was part of a four-page
spread. The headline was "if arthritis pain took your dog out o f the picture, where
would you be, besides a little lost?" The picture depicted a family frolicking with the
dog. The copy included:

You’ve always enjoyed those long walks with your best friend. Problem is, joint
pain and inflammation can sometimes make it difficult for him to lead the way.
That’s why it’s important to recognize the early signs. You’ll notice stiffness and
difficulty rising, walking and climbing stairs. Your dog won’t act like himself.
H e’ll resist your touch, he’ll whimper and he’ll limp.

Ask your doctor about an exciting advancement for treating runny noses,
ATROVENT® Nasal Spray. Inot a steroid! It’s the first in a unique class of nasal sprays
that actually stop runny noses where they start. Inot ananhhistwinei ATROVENT
Nasal Spray’s special inhibitors provide effective relief without insom nia
Iwont keepyouawakh[ or drowsiness. I^qnt putyouto;leep~| And it can be safely used
by children 12 years and older. ATROVENT Nasal Spray is available exclusively by
prescription. Only your doctor knows if it’s right for treating your runny nose. Though
most ATROVENT Nasal Spray users experience trouble-free relief, nasal dryness
(approximately 1 in 20 patients) and mild nose bleeds (approximately 1 in 10 patients) are
potential side effects* So ask your doctor about ATROVENT Nasal Spray, or call
toll-free 1* 888* ATROVENT (287*6836) for a free brochure and money-saving coupon.
S T O P IT F R O M T HE START.
See following page for additional
important information.

AN-6M
7K

ATROVENT8
"
N A S A L SPR A Y
(ipratropium bromide)
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This is a Pfizer product and the name was displayed prominently. The web site
address is www.pfizer.com/ah. The May 26th issue o f Newsweek had an ad for no specific
product other than publication material for Alzheimer’s ( fig. 26). The headline was,
"he's working to help Alzheimer’s patients remember, and that's helping families hope."
There was some testimonial material and snapshot pictures. No company or product
name appeared. There was a website address http://www.phrma.org.
Tim e’s May 5th issue had no product name, and no company sponsor. Rather, it
was much like the Alzheimer’s ad in that it was an awareness ad for Hepatitis. The
headline was, "get hip get tested get treated." A website address was given with
www.liverfoundation.org. This ad was similar to a pharmaceutical website. Tim e’s May
26th editions had the hepatitis ad (fig. 19) which has been described before. This ad
varied a bit in its layout, but the text and message was the same.
There were six website addresses from the magazine ads. Some were from
specific pharmaceutical companies; some were general information and were unnamed.
The sites are described and the research question most applicable to the particular
website is discussed. It should be noted that many of these sites contain elements that
are relevant to all o f the research question areas. All of the sites contain information.
Some o f this information is promotional in nature, some of it is manipulative, and some
of it transmits certain mores and norms.
The first website address that was explored was Flonase from Glaxo Wellcome
www.flonase.com (fig. 27). The homepage for this particular product was not the
homepage for Glaxo. Menu options for this page was understanding allergies, allergy
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hope.

"W hen I was a young student, people used to think that memory
loss and dementia w ere a normal part o f aging. Today we know
that in many cases, the real cause is Alzheimer’s disease. As a
pharmaceutical company researcher. I am committed
to finding ways o f treating this disease.”
"Currently, there are about 4 million people
in the United States with Alzheimer's disease.
Unfortunately, this number will dramatically increase
Brain celis from
as our population ages. My company is searching an Alzheimer's pooent.
for treatments that might slow down, halt or maybe
even reverse the progression o f
Are/ Unterbeck
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pharmaceutical company researcher

“W e think A lz h e im e r ’s d ise a se has
Several different Causes.” says Axel Unterbeck. a
pharmaceutical company researcher. "Some forms are
genetic while others might involve additional factors.
Because it affects mem ory and learning, it's one o f the
most complex diseases w e know of." Unterbeck and his
team o f researchers are working on genes that are linked
to Alzheimer's disease. "Four genes have been identified so
far," Unterbeck says. "These gene discoveries give us, for
the first time, a realistic hope to find a cure."
Call 800-8 6 2 -5 1 1 0 for our free booklet on Alzheim er's
or visit us on the internet a t http://w ww .phrm a.org. Find
out m ore by calling the Alzheimer's Disease Education
and Referral C enter a t 8 0 0 - 4 3 8 - 4 3 8 0 .
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Click on nose aoove for audio

Click here to receive your free allergy kit
including a $5 savings certificate.

[ Understanding A llergies ] [ Allergy Library ]
[ About Flonase ] [ More Cartoons ]
[ Product Info ] [ Free A llergy Kit ]
[ H om e]
Intended f o r U.S. consum ers only.
C opyrigh t G laxo W ellcom e Inc. 1996
A ll R ights R e se rv Figure #27
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library, about flonase, m ore cartoons, product info, free allergy kit, and home. All links
had expanded information about the product and all links link back to the hom epage o f
Glaxo. There w as also the additional item o f a $5 savings certificate w hen the browser
ch ooses a free allergy kit. This site provided the standard risk information that w as seen
in the magazine advertisement. There w as a prom otional aspect with this site as it gave
the view er an incentive to purchase the product w ith a discount feature. In this light it
could be said that there is som e manipulation in the site as there is the proverbial
“dangling carrot” to purchase the product w ith a rebate incentive.
The next w ebsite address explored w as from the A lzheim er’s advertisement

www.phrma.org. (fig. 2 8 ).This address actually w ent to a site called phrma for Am erica’s
pharmaceutical com panies. M enu item s included: Phrma hom epage, members, facts and
figures, health guides, current new s, industry issues, search, and new medicines in
developm ent. The site had a statement that Phrma membership, "represents
approximately 100 U .S . com panies that have a primary com m itm ent to pharmaceutical
research. T hese com panies are discovering, developing and bringing to market
m edicines that im prove our health and quality o f life, etc." W hen explored a bit, the links
did not g o to other pharmaceutical company sites. Som e recognizable companies w ere
m entioned in the text, but there w ere no hyperlinks. It is unclear at the tim e o f this
research i f Phrma is an umbrella name for specific com panies, or is an entity unto itself.
N o further data w as given. Product information w as presented, only in name rather than
affects and other relevant information. For this reason, this site w as manipulative in its
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**** Searching For Answers To Alzheimer's newi
PhRMA membership represents approximately 100 U.S. companies that have a primary
commitment to pharmaceutical research. These companies are discovering, developing and
bringing to market medicines that improve our health and quality of life~as well as reduce
the overall cost of healthcare.
While visiting here, be sure to stop by our sections on Drugs in Development, industry Facts
and Figures, and our consumer Health Guides series.
To find out more about issues concerning pharmaceuticals, look at Current News. This
section will discuss the hot topics and state issues that we are currently following.
Our new Genomics section provides a dynamic and accessible information resource on
emerging genomics-related issues for members of PhRMA and American Institute of
Biological Sciences (AIBS).
Thanks for visiting. We will continue to update this web site to keep you abreast of new
developments. If there is anything you would like to see here or have any comments please
let us know.
Sincerely,

Figure #28

Sidney Taurel
Chairman
Alan F. Holmer
President

I PhRlMA Home Page I Members I Facts and Figures 1Health Guides I
| Current News ) Industry Issues | Search | New Medicines in Development |
Copyright © 1996 PhRMA. All rights reserved.
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Pharmaceutical Research and Manufacturers o f America
1100 Fifteenth Street, NW
Washington, DC 20005
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information as it w as simply unclear what exactly product and com pany is featured. The

lack o f clarity enhanced the manipulative nature o f this site.
The next w ebsite address explored w as from the hepatitis ad. The hom epage had
the menu options of: information, ALF publications and videos, ALF services, activities,
and groups please sign our gu est book. What w as o f keen interest w as that the ad that
appeared in the m agazine w as the same ad by Schering-Plough in its hepatitis zone menu
option. On this particular page, there w as a link to the American liver foundation, but
there w as no link from the American liver foundation to the Schering site. This site
could be seen as being manipulative, as there w as confusion about the w ebsite address
given and the actual site. The “darkness” o f the ad and the seem ingly “other-worldly”
layout o f the ad also use scare tactics.
The next address exam ined w as www.migrainehelp.com. This w as for Imitrex
(fig. 29). The site had hypertext link options o f symptoms, treatment programs, detailed
diagnostic screening, complimentary support materials, and free subscription to
Headway. In addition there w as a main menu options w hich linked back to the Glaxo
W ellcom e hom epage and the option o f sharing your thoughts and experiences, which
w as in survey format. Imitrex option simply provided m ore information about migraine
headaches and little about the product other than lay perspectives and testim onials. This
site provided new s and information about the product. It could also be considered to be
correlative as it has strong prom otional emphasis on how the product aids the sufferer.
Z ocor w as the other prescription product from a pharmaceutical com pany
magazine advertisement, www.zocor.com w as the address (fig. 30).

Welcome to the
Migraine Resource Center
Figure #29

Glaxowelicome

Welcome to the Migraine Resource Center.
Those who suffer from migraine headaches know how painful, debilitating, and isolating
they can be. The good news is now there is more information available about migraine than
ever before, as well as promising treatment programs that may help you. If you think you
may have migraines - or have been diagnosed by a physician as a migraine sufferer - you
should see your doctor or allied health care professional to discuss possible treatment
programs.
Here in the Glaxo Wellcome Migraine Resource Center you can leam about some of the
triggers, symptoms, and treatment programs for migraine, take a free detailed diagnostic
screening, receive complimentary support materials such as a free subscription to Headway,
the migraine newsletter, and much more. Glaxo Wellcome Inc., a pharmaceutical research
and development company and sponsor of this site, is dedicated to the better understanding
and treatment of migraine.
As this site will be frequently updated, we urge you to visit us often - to get the latest news
as well as to share vour thoughts and experiences. We want the Glaxo Wellcome Migraine
Resource Center to be a place you turn to for the information and support you need to live
better with migraine.
To get started, click on Main Menu.
Next Topic
IMITREX*

(sumatriptan s u c c i n a t e )

Previous Topic

Home

1

IMITREX Tablets

Literature

1

Important Intormabon

Please see important information for IMITREX®^sumatriptan succinate^ Tablets.
Intended for US residents only.
©Copyright Glaxo Wellcome Inc. 1996
All Rights Reserved
Comments/Questions?: webmaster@migrainehelp.com
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www. z o c o r . com*
brought to you by Merck & Co.. Inc.
(Merck is also known as MSD, Merck Sharp & Dohme and others outside o f the USA.)

Merck & Co.. Inc.. is a worldwide health care company that is committed to developing and marketing
innovative products that treat conditions which impact your quality of life.
The information found here will help you to become better informed and educated about heart disease,
which could affect your health, lifestyle and future. We believe that the better informed you are, the
more involved you can become in partnering with your doctor to improve your overall health. To assist
us in providing you with the most appropriate information, please select one of the following:
z 1 am a resident of the United States of America.
z I am a resident of another country.

Merck develops products and services for a wide variety o f conditions, including high cholesterol, high
blood pressure, osteoporosis, enlarged prostate, glaucoma, and preventable diseases. Please visit our
Disease Infopark for more information.
When you have finished visiting ZO C O R .C O M , please use the buttons on the top of each page to
navigate to sections o f the Merck site to view information about other medical conditions and products
that Merck has developed.
Copyright © 1996 Merck & Co.. Inc.. Whitehouse Station. NJ, USA. A ll rights reserved
* ZOCOR ® (simvastatin) is a trademark o f Merck & Co.. Inc.. Whitehouse Station. NJ, USA, and
registered in the United States Patent and Trademark Office.
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M enu items for this site simply w ere all directed back to the M erck hom epage. N o
explanation w as given about the product. This w as a manipulative tactic as the w ebsite
advertised in the m agazine stated one thing, but the actual site w as something else.
Pfizer had the m agazine w ebsite address o f www.pfizer.com/ah. This site w as for
the animal health care products that w ere m entioned earlier under this com pany’s
hom epage description.

M enu options for this site included: about Pfizer animal health,

veterinarians, pet ow ners, and livestock. The information w as fairly lengthy, how ever it
w as m ostly for the veterinarian as it is technical in nature.
What w as o f interest w ith all o f these ads w as that the ones with w ebsite
addresses w ere not necessarily the pharmaceutical com panies that appear on D un’s
rankings. G laxo W ellcom e had tw o ads for tw o different products but w as ranked
outside o f the given parameters. M erck seem ed to be active in prom oting its w ebsite as
its product features the address for its drug.

Chapter 5
DISCUSSION
The present research investigated six drug com panies advertising
pharmaceuticals on the Internet as w ell as three m agazines advertising pharmaceuticals.
The findings provided a broad background for understanding how drugs are advertised
on the Internet com pared to other, m ore traditional mediums. From the investigation
three main discussion points emerged. T hese points can be illustrated by using the
theoretical framework o f Lassw ell and Wright (1 9 6 0 , 1976) and D oris Graber (1 997).
The three areas o f discussion are: m agazine portrayal, pharmaceutical com pany w ebsites,
individual drug advertisem ents and connections betw een the tw o mediums.
W hat the results show ed w as unexpected. From the literature review , one
could extrapolate that the free flo w o f information that the Internet allow s for is o f
concern regarding the lay population and pharmaceuticals (F D A and the Internet, 1996).
What w as surprising about the findings w as that overwhelm ingly there w as very little
information about pharmaceutical products them selves. The vast majority o f the
information that w as presented w as information about the pharmaceutical com panies,
their role in the consum er culture, their role in the business culture, and generalized
healthcare information. Little i f any o f the information involved in the w ebsites dealt
w ith pharmaceuticals.
Com pany history and com m unity relation information to o k up a lot o f space
w ith each com pany w ebsite. M uch o f the information presented w as geared tow ard the
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consumer in a public relations manner. Novartis had a management letter w ith its ‘V h o

w e are” link that gave the m ission statement for the company.
A s one o f the w orld’s leading life sciences companies, N ovartis is dedicated to
creating value for its custom ers in the areas o f Healthcare. Our commitment to
Health, Safety and the Environment (H SE ) is part o f this dedication and is
inseparable from our activities, our identity and our values. E xcellence in Health,
Safety and the Environment is not at odds with, but is rather intimately connected
to our goal o f providing the w orld with innovative products.

All o f the com pany w ebsites had similar item s for customer relations or other such text,
never w ere specific products m entioned.
The drug information that w as presented on the w ebsites w as limited. Specific
product names w ould be m entioned (i.e. Claritin) as a link w ould be built around the site
o f that particular product, but no m ore detailed information could be retrieved or w as
offered in the majority o f cases. M o st product-specific links merely stated “ask your
doctor” type referrals. A lthough little information w as given, this type o f link does
confirm the literature in that com panies are targeting the end-user to direct the
physician’s prescriptive inclinations (Consum er Reports, 1992).
B ecau se the research show ed that pharmaceuticals are big business (SIC,
1996), the interest in monetary performance is logical. The obvious drive for the bottom
line is fueled by the advertising expenditures earmarked by the com panies (Conlan,
1996). All o f the w ebsites explored had a financial link w hich gave com pany stock
information. N ovartis, as w ell as a few o f the other com panies had actual links to other
financial w ebsites to give the m ost current stock information. Again, specific
pharmaceutical products w ere not mentioned.
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O f all the possible links, link options and their menu options, research and
developm ent seem ed to be the best place to find detailed information on specific
pharmaceutical products. H ow ever, all o f the w ebsites had public relation information
w hich w as akin to com pany histories, but only a few sites contained information w here
specific products w ere mentioned. Flonase from G laxo W ellcom e w as an exam ple o f
specific product being mentioned. The w ebsite had information about about the product
and general allergy information. Schering Plough had Tinactin and Claritin information
and specific sites built around those products. H ow ever, there w ere no other products
m entioned in any o f the w ebsites w hich gave specific product information for other types
o f drugs. A thlete’s foot spray and allergy m edicine were the featured products. N o anti
depressants or other schools o f pharmaceuticals w ere mentioned. B M S research and
developm ent link w as typical o f the other com panies.

(PRI) Pharmaceutical Research Institute is headquartered in Princeton, N ew
Jersey, and is recognized leader in discovering and developing novel, costeffective pharmaceutical therapies that improve p eop le’s health and quality o f
life. The PR I’s long tradition o f preeminent scientific investigation has led to
numerous advances in pharmaceutical treatment and prevention across the
spectrum o f medicine.

Magazine advertising
It is interesting that, in researching this area, much o f the mainstream press has
reported the issue o f health and health care. For instance, three o f the eight m agazine
issues during this research had cover stories on som e form o f health. The M ay 2 6 th
edition o f Newsweek had Asthma as its main cover story. Time had "How w e get

*

addicted" as its cover story for the M ay 5

th

edition, and "Natural Healing" as its M ay 12

th

cover story. Far from drawing any conclusions, it is at least w orth noting that these
issues all had som e form o f pharmaceutical advertisements betw een their covers. The

Newsweek M ay 12th edition had a cover story on China, and absolutely no drug
advertising. N o generalization can be drawn from this; how ever, these facts help solidify
the public’s awareness and concern about health care in all fashions and forms.
The magazine ads tended to be loaded with information. Som e o f the ads w ere
balanced with lay term inology and traditional advertising approach presenting
feature/benefit, yet there is little doubt that m uch o f the ads w ere directed tow ard th ose
in the medical profession. The technicalities o f many o f the ads support this observation.
M ost o f the ads w ere consum er-oriented in that they had elaborate layout with color
graphics and photographs. M uch o f the text w as for the lay person w ith information
about heartburn interlaced w ith technical jargon.
Taken as a w hole, the m agazine ads did not convey a surveillance function in
providing “n ew s.” The information presented did not necessarily inform either. M ost o f
the data presented in the m agazine ads gave technical information and attempted to find
identification w ith the individual looking at the ad. For this reason, all o f the m agazine
ads w ere considered correlative in nature. They editorialized on the information given.
This w as the selling point o f the material presented. For example, headaches are not
pleasant, but the ad for Glaxo's Imitrex show ed a rebirth o f sort for the user o f the
product. M o st assuredly, these can b e labeled as socialization. They function to
com m unicate values, and norms from the members o f a society to a newcom er. I f one
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w as a first tim e user o f this product, one w ould not k now w hat to expect. Such graphics

helped to illustrate what that individual can expect. It is not just aspirin, it is freedom.
People w ho g et older and need m ore medical assistance are prone to be “initiated” into
this culture by their peers, and m ost assuredly the com panies. There are w ays that are
presented by the ads to gather m ore information, and adjust o n eself to the jargon. 1-800
numbers are given, as are guideposts to see i f one qualifies for the use o f the product via
a checklist o f symptoms. I f one has these sym ptom s, one qualifies for the treatment.
Entertainment did not necessarily apply to the m agazine ads. They either informed in a
minor w ay, helped the audience identify w ith the product, or point the w ay to more
information. Graber's (1 9 9 7 ) manipulation function did com e into play by the sheer
nature o f the medium. The ads attempted to entice the consum er, create empathy, or
create a need by playing upon the possibility o f the consum er’s discomfort. Pain and
“dis” ease are often show n in these ads. Perhaps this w as done to create empathy with
the viewer. A sense o f identification with an ad is apt to draw a viewer. This type o f
logic can be traced back to transmitting a value or a culture.

Pharmaceutical websites
The com pany w ebsites offered a host o f information. Perhaps one o f the
biggest features o f the w ebsites w as the financial news. These sites w ere all about
information, from giving historical background on diseases to providing press releases
about new product developm ent. They all qualified for the surveillance function. The
correlative function w as a bit m ore difficult to apply to the com pany websites.
Interpreting the environment w as not the primary function o f the w ebsites. I f anything,

the m agazines did a better job o f correlation. They defined diseases or symptoms. The
w ebsites did not interpret the environment.

M oreover, the m agazine advertisements had

more prom otion o f the product in their content than the com pany w ebsites. Initial
contact w ith a w eb page gave the brow ser many options for gathering information and
different aspects o f the com pany and health care as an entity. In examining the w ebsites
and Internet as a w hole, it could be argued that they do in fact transmit information to
"new" w eb users. There are several links on the company sites that allow for a tutorial
showing h ow to navigate on the w eb. An example o f this w ould be Lilly’s "search this
w eb site" option.
Entertainment did play m ore o f a role in the com pany w ebsites than it did in the
magazine ads. A s the findings show ed there w ere a mix o f entertainment and
educational devices. H ow ever, Postm an (1 9 8 5 ) suggests that through technologically
advanced devices, information dissem ination is not necessarily educational.
W e face the rapid dissolution o f the assumptions o f education organized around
the slow -m oving printed w ord, and the equally rapid em ergence o f a new
education based on the speed-of-light electronic image. There is a new
conception o f know ledge and h ow it is acquired (Postm an, 1985, p. 145).

There w ere "interactive" processes that a browser could engage in. V ideos
could be ordered and cartoons appeared on som e sites. There w as m ovem ent in som e o f
the graphic layouts o f the hom e pages. For an example, M erck had m oving graphics o f
balloons as w ell as quizzes that people could play. F A Q ’s (frequently asked questions)
w ere another option provided by many o f the sites.
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Manipulation on the W eb is difficult to assess. The very nature o f the Internet
allow s for the brow ser to manipulate and navigate through the sites. In so doing, the site
itself manipulates the brow ser by providing information and situations that the brow ser
must "manipulate" in order to access further information. B y its very nature this is a
manipulative medium, but its interactive nature puts the media user in charge o f key
decisions. The com panies control by limiting options on a particular site.

Magazine and website addresses
The m agazine ads w ith w ebsite addresses fall under the surveillance function
because the m agazine ads provide the information (the w ebsite address) to the audience.
It is providing information and new s. M ost o f the ads asked the consum er to, "visit our
w eb site." The relationship b etw een the tw o mediums is not correlative in nature. It is
true that the m agazine ads contain strong graphics, but there is no editorializing around
the naming o f the w ebsite address, other than the tame incitement o f “com e visit.” The
strongest function o f the relationship betw een the tw o m edium s w as that there w as a
socialization process. The m agazine ads w ere communicating information, perhaps even
values and norms from one generation to another. The literature review has shown that
the Internet is an ever-grow ing medium (Liebman, 1995).

The listing o f a w ebsite in a

traditional medium like a m agazine ad is socialization. Entertainment w as not evident in
this relationship, how ever manipulation is. B y the sheer function o f a W eb listing in a
traditional medium such as a m agazine, the audience is being manipulated to "seek more
information" by researching another medium. Such listings m ove the culture by
suggesting u se o f the w eb has b ecom e a social norm.

101

Even at the tim e o f this research, there is continued grow th in the Internet and
health care. Patients w h o want to k now the recom m ended treatments for their m edical
problems will have a place to turn to in cyberspace under the new National Guideline
Clearinghouse. This w ebsite will post the full range o f treatment guidelines. The project
is being developed with the American M edical A ssociation and the American A ssociation
o f Health Plans, w hich represents health maintenance organizations and other managedcare plans.
This type o f developm ent is what fuels the F D A ’s concern over this new
technology and the general public’s access to such information. The pharmaceutical
com panies have a history o f being driven by the bottom line, and as a result, the
expansion into this new medium is cause for som e concern as a unique relationship is
beginning to form w ith an information, te ch n o -sa w y public, and a profit driven industry.
H ow ever, what this research has shown is that there is no illicit behavior goin g
on with pharmaceuticals on the web. I f anything, there is a lack o f information in this
regard. The drug com panies have a plethora o f information but very little o f it is in
regards to actual pharmaceutical products. Y et, i f the current players continue to be in
the mix, there is great incentive, and very little cause for restraint in supplying the
consumer with that information.

Limitations of the study
The major limitation o f the study is the source that w as examined in trying to
find information about pharmacueticals. A s the F D A is on guard about h ow and what
information is presented (Critser, 1996) and it appears that pharmaceuticals have a w ell
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docum ented history o f using som e questionable strategies for selling their products
(Braithwaite, 1984), it w ould be surprising if the pharmaceutical com panies did prom ote
their products on the Internet.

Perhaps a better study w ould b e to examine other

sources on the Internet that are prom oting certain drug products. It could be that there
is a group, individuals, com panies, or other entity that is providing in-depth information
about drugs that the consumer is looking for, and is posting this information on the
Internet.
Another limitation o f the study could be the timeframe o f the research which
w as not ample to look at trends and changes. A one-m onth period is g o o d to get an
initial reading, but as it w as discovered, the w eb sites did not change in any dramatic way.
Perhaps w ith a three-month w in d ow o f tim e or longer, one w ould be able to see more
changes in the text and layout o f the w ebsites.

Over time, a long-term analysis could

study evolution o f the sites. Another limitation o f the study is the choice o f the magazine
medium. T elevision might be a m ore comparable medium. H ow ever, one must take into
consideration, that television advertising o f pharmaceuticals is a relatively new
developm ent. In addition to this point, there is very little “tex t” in a television ad.
M agazine advertising and the w ebsites are com patible for the fact that they are both copy
heavy. Another possible angle from w hich to study this issue is by focusing on the
specific product rather than company. T o trace the product lifecycle might be m ore
beneficial than to track it through the various mediums it may appear in.
The framework in w hich the study w as conducted might also be another
w eakness. Functional theory (W right, 1976) has vast limitations. It is descriptive in
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nature rather than predictive. W hat is o f concern to the F D A is the possibility o f
misinformation being disseminated on the Internet w ithout any regulations. What w ould
be m ost beneficial is to attempt to predict the likelihood o f this situation occurring.
What the research found w as that there is virtually no drug information being presented
by the pharmaceutical companies.
W hat is o f concern is the potential pow er these pharmaceutical com panies have
in their drive for the bottom -line. (M cQuail, 1987) suggests that the role o f mass media
is determined essentially by econom ic forces. In essence, the basic econom ic law o f
supply and demand could dictate the future o f the Internet and w hat information is
provided regarding prescription pharmaceuticals. I f there is a great enough demand by
the public, th ese com panies are prone to com ply. A s it w as stated earlier in the research,
there are no set regulations by a governm ental body for this specific type o f information
for the Internet.

Future research
The m ost interesting aspect o f this research w as to learn about the practices o f
the pharmaceutical industry. Obviously, selling drugs is big business, and in the
consum ption driven econom y o f America, the bottom -line is that much more deliberate.
W e are consum ers o f information. It is a major part o f our civilization. The purpose o f
the information industry is to facilitate access to the precise information needed at any
specific tim e and place. W olpert (1986) believes that know led ge is for three purposes:
First, for fun or social interaction; second, for education, as essential building block facts
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that are required or may be advantageous to acquire: and third, for making decisions or
assisting in action choices.
Information retrieval system s and the information industry are concerned with the
creation, organization, and dissemination o f know ledge from databases and the
related aspects o f processing, marketing, and communication. For an econom y
to develop, it must have a g o o d information system. H ow ever, m ost econom ists
have ignored the basic rules o f information (W olpert, 1986, p. 11).

Future research might b e beneficial for both consumers and the governm ent if
the information that is presented by these com panies on their w ebsites could be
scrutinized in detail. One w ould suspect that w ith the history o f the com panies, there
w ould apt to be stretches in the “truth” presented on the w ebsites. Another aspect for
study w ould be to examine possible trends in the grow th or decline o f name brands on
the sites, and com pare that to the market share o f that particular product.
The Internet has been im possible to ignore. Even people w ho are not com puter
ow ners and do not have access to get on-line, have been made aware o f its
grow ing popularity and effects on the population. It is sure to evolve into a
m edium o f w hat is n o w considered to be the mass mediums; television, radio, and
print. Credibility is an issue. The Internet makes few such claims at the m om ent,
and it is possible that the concept o f credibility will also change as a result.
Traditional mass media have addressed the issue within their organizations, hiring
editors and fact checkers to determine what information is accurate. Source
credibility w ill vary on the Internet,, with commercial media sites carrying
relatively m ore credibility and unknown sources carrying less. A m uch greater
burden w ill be placed on the user to determine h ow much faith to place in any
given source. (Morris & Ogan, 1996, p. 44)

Such research as to h ow the Internet can actually com ply to the definition o f a
mass medium m ight help determine the validity o f information. Y et, i f the Internet is not
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considered a mass medium, how can the information that is presented on the Internet be
critiqued?
N itcher (1 9 8 9 ) sees the grow ing tendency to view health as som ething one can
obtain through the consum ption o f pharmaceuticals. A s self- m edication is by far the
m ost com m on medical action (V an der Geest, 1996) it is natural because it is convenient
and econom ical. Self-m edication is encouraged in reaction to overdependence on
medical services. For consum ers, it is a m ovem ent to assum e greater responsibility over
their ow n health. For the state, it is a w elcom e opportunity to econom ize on health care.
It also benefits the pharmaceutical industry.

Research could be done on the possible

trends that may be occurring w ith populations in h ow they are receiving their medical
information as w ith the exam ple o f w ebsite addresses in m agazine ads, and whether or
not people respond to th ose addresses and go to the w ebsites.
To take it a step further, a viable topic o f study could be to see if people are
reactive or pro-active to pharmaceutical advertising on the Internet. The possible
number and age o f a brow ser could help define whether or not the medium cross-over is
effective, and with w hich dem ographic groups, if any.
This early exploratory study o f the Internet provided a starting point for fUture
study o f advertising on the Internet. W hile this study did not set out to explore the
effects o f this new type o f advertising o f pharmaceuticals, such studies in the future are
inevitable. H o w many people use the Internet as a source o f m edical information and a
profile o f w ho they are w ill be keys to understanding the effect o f this new

106
comm unication technology. Continued system atic research by scholars is needed on the

Internet in order to see possible abuses o f the system.

Chapter 6
CONCLUSION
The specific topic o f pharmaceuticals being advertised and prom oted on the
Internet is becom ing a greater issue in the public’s mind. A t the conclusion o f this
particular study there w ere several articles in national publications that addressed this
matter. W hat may be the impetus for this grow ing concern is the fact that the F D A has
eased its regulations o f television advertising for pharmaceuticals. The possible risks
and/or side effects o f taking a prescribed m edication no longer are needed to be included
in television advertising. Simply, all that is needed is the m ention that som e risks may
occur and an individual’s physician should be consulted.
W ith the broad and ever grow ing appeal o f the Internet, access to certain kinds
o f information is cause for alarm in som e quarters. What this study has found may only
be the initial prospectus for w hat is sure to becom e a hot topic in the national dialogue.
Privacy issues abound in light o f the information age, but with the open access to
information concerning health factors, a peculiar twist em erges. D octors are the experts
in consulting our health. Y et, i f the lay person can diagnose and then prescribe his or her
ow n treatment based on the amassing o f information, the doctor may becom e only a
middleman in the pharmaceutical delivery cycle.

M oreover, the governm ental role that

has been the definitive gatekeeper for public health may find itself in jeopardy as more
and m ore people are apt to turn to their ow n devices in the information age to m edicate
them selves.
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This study has drawn no specific conclusions on this topic. In fact, at the tim e

o f this study, the mounting fears and trepidation o f certain groups w ere simply
unfounded. The majority o f the information that w as displayed by the pharmaceutical
com panies on the Internet w as not product specific. The majority o f the information
could be found in other mediums and other sources. H ow ever, this does not mean that
specific pharmaceutical information is not available. The study simply did not explore
other options o f this kind on the Internet.
M ost com pany w ebsites explored in this study had lots o f information
regarding the com pany, health problems and concerns, and other varied information that
did not involve specific pharmaceutical products. There w as no cause and effect, nor
direct problem /solution scenarios. In other w ords, there w as no direct linking o f a
particular ailment to a particular drug.
H ow ever, as there have been an easing o f F D A restrictions towards one
medium, it may not be farfetched to concede to the possibility that the same may be true
for the Internet in the future.

Appendix A

The Companies

Bristol-Myers Squibb Company
William M cLaren Bristol and John Ripley M yers founded bristol-M yers Squibb
Company in 1887. The merger o f Bristol-M yers and Squibb Corporation in 1989
marked the largest single stock transfer in the history o f the health care industry at that
time. The com pany dedicates over $20 million a year tow ard philanthropic endeavors.
The company is the parent o f high-tech operating units involved in pharmaceuticals,
health care products and other areas o f technology. Producer o f cardiovascular, anti
cancer, anti-infective and other such agents, its products include Capoten and Azactam ,
w hich are used as a m edication for heart failure.

Pfizer Inc.
Pfizerlnc. is a research-based, global health care company. Their products are available
in more than 150 countries. This com pany is the parent for many operating units
involved in the manufacture o f hospital products, pharmaceuticals, and chemicals. Overthe-counter drugs include B en Gay, a topical muscular pain reliever, and Rid, a lice
treatment. They are also the producers o f anti-infective agents, psychotropic and

cardiology drugs. Products include Unasyn and Cefobid antibiotics, Z oloft
antidepressants, and Cardura, a cardiology drug. Pfizer w as form ed in 1849.

Merck
M erck w as established in the U nited States in 1891, began its research program in the
1930's and rapidly becam e know n for its achievem ents in cortisone, and penicillin.
M erck estim ates itself as conducting 5 percent o f the w orld’s pharmaceutical research.
M erck is the parent o f high-tech units involved in the research, developm ent and
manufacturing o f pharmaceuticals and chemicals.

Ciba-Geigy
This company is a non-U .S. com pany founded in Switzerland in 1940. C iba-G eigy is a
producer o f drugs for arthritis, cardiac treatment, hormone balance, sm oking cessation,
attention deficit disorders, and obsessive-com pulsive behavior treatment applications.
Other products include laxatives and analgesics. Products are sold to the m edical and
pharmaceutical industries. Habitrol, the nicotine patch, and Ritalin for attention deficit
disorder are am ong its product line.

Eli Lilly
Founded in 1876, this com pany is a manufacturer o f injectable and oral antibiotics, drugs
and agents. Parent/holding com pany w ith units involved in the m edical pharmaceutical
and biotechnology industries. The bulk o f revenue is derived form activity in the
pharmaceutical industry. It has 2 6 ,0 0 0 em ployees with a 4% grow th in the prior year.
A m ong its product line is Prozac, an antidepressant drug, and Humulin, a drug for insulin
treatment.

Schering-Plough
Formed in 1936, Schering-Plough is the parent o f operating units involved in
prescription and over-the-counter pharmaceuticals, vision care and animal health
products, sun care and fo o t care products and research and developm ent o f allergic and
inflammatory disorders and cardiovascular diseases. It has 2 1 ,0 0 0 em ployees with a 1-%
em ploym ent reduction in the prior year. Drixoral, a sinus m edication and Dr. Scholl’s
are among its product line.

A p p e n d ix B
C ib a -G eig y /N o v a rtis

In Basel, Switzerland in late D ecem ber 1996, the United States Federal Trade
Com m ission (FTC) granted provisional approval to an agreement with C iba-Geigy and
Sandoz, clearing the w ay for the creation o f Novartis. W ith core businesses in health
care, Agribusiness and Nutrition, N ovartis had, in 1995, an R & D investment o f 3.5
billion S w iss francs on pro-forma sales o f 36 billion Sw iss francs. Novartis w as formally
founded in early 1997 w hen the com pany w as registered in Switzerland, and its shares
began trading soon thereafter on the Sw iss stock exchange. The merger w as conducted
through an exchange o f shares. This m erger becam e active in the United States on
M arch 7, 1997.
B ecause o f the timing o f this merger and the study being conducted by the
researcher, som e discrepancies do occur. A t the tim e o f the study, all three entities w ent
by their individual namesake, w hile referring to the N ovartis merger, but remained their
ow n entity. W hile som e o f the figures w ill be off, and som e are simply non-existent, the
validity o f the study does not appear to be infringed upon. For the sake o f argument, the
researcher w ill use Ciba and N ovartis interchangeably, and keep the figures o f the D u n ’s
report, w hich are indicative o f Ciba’s performance. Since N ovartis is a new holding,
there is no ranking for it in D u n ’s or otherwise.

REFERENCES
Aaker, D., Batra, R. & Meyers, J., (1992). Advertising Management. 4th Ed. Englewood cliff, NJ:
Prentice-Hall International.
Abramson, J.B., Arterton, F.C. & Orren, G.R. (1988). The Electronic Commonwealth. New
York: Basic Book, Inc.
Adams, D. (1989). FDA regulation o f promotion o f drugs: a legal primer. Drug Information
Journal, vol. 23, pp. 625-633.
/Advertising Age. (1996). LAB Misstep, vol. 67, iss. 27, Jul. 1, p. 15.
Alperstein, N.& Peyrot, M. (1993). Consumer awareness o f prescription drug advertising.
Journal o f Advertising Research, v.33, iss. 4, pp. 50-56.
Babbie, E. (1995, seventh edition). The Practice of Social Research. Belmont, CA: Wadsworth, p.
204.
Bowman, M. (1994, April). Pharmaceutical company/physician interactions. Finding the balance.
Archives o f Family Medicine, vol. 3, pp. 317-318.
Braithwaite, J. (1984). Corporate Crime in the Pharmaceutical Industry. London: Routledge &
Kegan Paul.
Brakeman, L. (1996). Using the Internet for marketing purposes. Managed Healthcare, vol. 6, iss.
2, pp. 3 8 -4 0.

Brannstrom, I., & Lindblad, B. (1994). Mass communication and health promotion: The power of
the media and public opinion. Health Communication. 6, pp. 21-36.
Carlson, J. (1996, June). Adding the Internet to your marketing strategy. Medical Marketing and
Media. 31, 6, pp. 44-52.
Cohen, E.P. (1988). Direct-to-the-public advertisement o f prescription drugs. New England
Journal o f Medicine, vol. 318, pp.373-375.
Conlan, M. (1996, July, 8). In-your-face pharmacy: will the boom in RX ads aimed at consumers?
Drug Topics, vol. 140, p.92.
Consumer Reports. (1992, March). Miracle Drugs or Media Drugs? pp. 142-146
Corptech Directory o f Technology Companies. (1996, 11th U.S. edition).
CQ Researcher. (1996. January-December). Congressional Quarterly: Washington.
Critser, G. (1996). Oh, how Happy we will be. Harper's Magazine, pp. 39-48.
D ’Emanuele, T. (1995, November). Internet no panacea-but it’s getting there. Information World
Review. 108, pp. 22-23.
Deamer, R.(1994, December). Value and need for pharmaceutical promotion disputed. Archives
o f Family Medicine, vol. 3, p. 1033.

Doutherty, M. (1993, April, 4-7). Assuring the value o f marketing. Presented at the
Pharmaceutical Manufacturers Association Annual Marketing Section Meeting; Tucson, Az.
Edell, J, & Staelin, R. (1983, June). The information processing o f pictures in print
advertisements. Journal o f consumer research, vol. 10, pp. 45-61.
Edelson, R.C. (1980). Overview: regulation o f prescription drug promotion. N.J. Lawyer, pp.
33-37.
Emerging Issues in Pharmaceutical Cost Containment. 1992, 2: 1-12
Friedmann, R. & Zimmer, M. (1988). The role o f psychological meaning in advertising. Journal
o f Advertising, vol. 17, pp. 31-40.
Gantz, W., & Rainbow, (Winter, 1980). Approaching invisibility: The portrayal o f the elderly in
magazine advertisements. Journal of Communication, pp. 56-61.
Gellhom, E. & Levin, R. (1990). Administrative law and process in a nutshell. St. Paul. West.
Gilbert, S. (1992, May). Drug wars: the high cost o f getting well. Redbook. 179, pp.46, 50, 52.
Gilbert, S., Chetley, D., & Andrew, (1996, September/October). New trends in drug promotion. 6,
5, pp. 162-167.
Goldman, R., & Monatgne, M, (1985, August 12). Marketing ‘mind mechanics:’ Decoding
antidepressant drug advertisements. Journal o f the American Medical Association, pp. 1047-1058.
Goldstein, A., (1994, December). Pharmacoeconomic considerations in pharmaceutical company
promotions. Archives of Family Medicine, vol. 3. p. 1034.
Graber, D. (1997, fifth edition). Mass Media and American Politics. CQ Press.
Grady, D., & Podolsky, D.M. (1988, December, 7). Mail-order drugs from abroad. American
Health, pp. 11-12, 14.
Gronstedt, A. (1997). Internet: IMC on steroids. Marketing News, p. 9.
Harvey, D. (1989). The condition o f post modernity. Oxford: Basil Blackwell.
Ito, Y. (1981). The ‘Johoka Shakai’ approach to the study o f communication in Japan. Mass
Communication Review Year Book. London: Sage Publications.
Jamieson, K. & Campbell, K. (1997, fouth edition). The Interplay o f Influence. News.
Advertising. Politics, and the mass media. Belmont, CA: Wadsworth.
Kamat, VR. (1995). Reconsidering the popularity o f primary health center in India: a case study
from rural Maharashtra. Social Science Medicine. 41, pp. 87-98.
Keenan, D. (1996, June). The law and the Internet. Accountancy, vol. 117, iss. 1234, p. 92.
Kessler, D., & Pines, W., (1990, November, 14). The Federal Regulation o f Prescription Drug
Advertising and Promotion. Journal o f the American Medical Association, pp.2409-2415.

Kessler, D., Rose, J., Temple, R., Schapiro, R.& Griffen, J. (1994). Therapeutic class wars-drug
promotion in a competitive marketplace. New England Journal o f Medicine. 331, pp. 1350-1353.
Krupka, L. & Vener, A. (1985). Prescription drug advertising: trends and implications. Social
Science Medicine. 20. pp. 191-197.
Lancet. The. (1993, June, 12). Drug Promotion: stealth, wealth, and safety, pp.9-11.
Lancet. The (1996, September, 21). Secrets about drugs are not healthy, vol. 348, p.765.
Lasswell, H. (1960). Mass Communications. Urbana: University o f Illinois Press.
Lemonick, M. (1996, February, 19). Border Bargains. Time, p. 54.
Levy, R. (1994, April). The role and value o f pharmaceutical marketing. Archives o f Family
Medicine, vol. 3, pp.327-332.
Liebman, M. (1995, November). Internet: Can drug marketers afford not to participate? Medical
Marketing & Media, vol. 30, 11, pp. 18, 24.
Lindlof, T. (1995, Third edition). Qualitative Communication Research Methods. Thousand
Oaks, CA: Sage Publications
Lord, M. & Arrarte, A. & Dean, J.& Boram, J. (1992, May, 11). Underground medicine. U.S.
News & World Report, pp. 62, 64-65.
Lucas, A (1996, April). Law comes to Tombstone. Sales and Marketing Management, vol. 148,
iss. 4, p. 100.
McMahon, F. (1996). Advertising prescription drugs to the public. New England Journal of
Medicine, pp. 314-24.
McQuail, D. (1987). Mass Communication Theory. London: Sage Publications.
McQuail, D. (1992). Media Performance: Mass Communication and the public interest. London:
Sage Publications.
Mackowiak, J. & Gagnon, J.P. (1985). Effects o f promotion on pharmaceutical demand. Social
Science Medicine, vol. 20, 11, pp. 1191-1197.
Marquez, F. (1977, Autumn). Advertising content, persuasion, information or intimidation?
Journalism Quarterly, vol. 54, pp. 482-491.
Medical Advertising News. (1997). Market forces: strategies undone, vol. 14, 12, p. 40.
Miles, M. & Huberman, M. (1984). Qualitative data analysis. A sourcebook o f new methods.
Beverly Hills, CA: Sage Publications.
Mitchell, A., & Olson, J. (1981). Are product attribute beliefs the only mediator o f advertising
effects on brand attitude? Journal o f marketing research, vol. 18, pp. 318-332.
Moncavage, M. (1996). Phone interview 2/12/97. Public Health Advisor for Division o f Drug
Marketing, Advertising and Communications for the FDA.

Moriarty, S. & Popovich, M. (1991). Newsmagazine visuals and the 1988 presidential election.
Journalism Quarterly, vol. 68, pp. 371-341.
Morris, M. & Ogan, C. (1996). The Internet as Mass Medium. Journal o f Communication, vol.
46, winter, pp. 39-50.
Nitcher, M. (1989). A question o f "medicine answering" health commodification and the social
relations o f healing in Sri Lanka. Cultural Medicine Psychiatry, pp. 367-390.
PTC Business News. (1997). Policing the ether: OTC sales on the Internet. FDA raises concerns
about pharmaceutical being sold over the Internet, 63, p. 18.
Patz, D. (1993, July, 1). Will drug ads go though withdrawl? Folio: The magazine for magazine
management, vol. 22, p. 19.
Petroshius, S. & Titus, P. (1995, November/December). Physician attitudes toward
pharmaceutical drug advertising. Journal o f Advertising Research, pp. 41-50.
Percy, L., & Rossiter, J. (1982). Mediating effects o f visual and verbal elements in print
advertising upon belief, attitude, and intention responses. Advertising and Consumer Psychology.
Lexington, MA: Lexington Books, pp. 171-196.
Postman, N. (1985). Amusing ourselves to death.. New York: Viking Penguin Inc.
Rheinstein, P. & McGinnis, T. (1996, July). Ways to access FDA information, American Family
Physician, vol. 54, 1, pp.353-358.
Sanders, C. (1996). Media, politics and the World Wide Web: A qualitative analysis o f the 1996
presidential campaign. University Library, University o f Nebraska at Omaha.
Snyder, K. 91996, December, 9). FDA evaluation Internet ads for drugs and devices. Drug
Topics. 140, 23, pp. 130-132.
Sherman, W. (1992, March, 4). Underground pharmacies. Longevity, pp. 60-62, 64, 66, 68-69.
Smith, M.C. (1980). The relationship between pharmacy and medicine. Prescribing Practice and
Drug Usage. London: Croom Helm. pp. 157-200.
Smith, P. (1990). African-American phot coverage in Life, Newsweek and Time, 1937-1988.
Journalism Quarterly, vol. 67, pp. 128-137.
Straubhaar, J. & LaRose, R. (1997). Communications media in the information society.
Wadsworth publishing.
Thompson, R. (1994, December). Pharmaceutical advertising, Archives of Family Medicine, vol.
3, pp. 1032-33.
Ubois, J. (1996, August, 12). He who pays the piper. Midrange Systems, vol. 9, iss. 12, p. 50.
U.S. Food and Drug Administration. (1996, October, 16, 17). Department o f Health and Human
Services. FDA and The Internet. Advertising and promotion o f medical products. Quality Hotel
8727 Colesville Road, Silver Spring, Maryland 20910. Intemet-http://www.fda.gov.

Van der Geest, S. (1996). The Anthropology o f pharmaceuticals, Annual Review o f
Anthropology. 25. pp. 153-178.
Wade, V. & Mansfield, P. & McDonald, P. (1989, November, 25). Drug companies’ evidence to
justify advertising. The Lancet pp. 1261-1263.
Waud, D. (1992). Pharmaceutical promotions-a free lunch? The New England Journal o f
Medicine, vol. 327, 5,pp.351-353.
Wellcome Trends in Pharmacy, Jan. 1993: 3-4.
Wilkie, T. (1996, May, 11). Sources in science: who can we trust? The Lancet vol. 347, pp.
1308-1311.
Williams, J. & Hensel, P. (1995). Direct-to-consumer advertising o f prescription drugs. Journal
o f Health Care Marketing, vol. 15, l,pp.35-41.
Wind, J. (1994, April). Pharmaceutical advertising, a business school perspective. Archives o f
Family Medicine, vol. 3, pp.321-323.
Winters, P. (1993, January, 18). Prescription drug ads up; information hungry-boomers to fuel
continued growth. Advertising Age, vol. 64, p. 10
Wolpert, S. (1986). Economics o f information. New York: Van Nostrand Reinhold Co.
World Almanac. (1996). World Almanac Books, p. 383.
Wright, C. (1976). Functional Analysis and Mass Communication Revisited. The Uses o f Mass
Communication. N ew York: Random.
Wright, P. (1979). Concrete action plans in TV messages to increase reading o f drug warnings.
Journal o f consumer research, vol. 6, pp. 256-269.

